Canine Distemper Virus in Wildlife

1. Overview and Taxonomy of Canine Distemper Virus in Wildlife

1.1 Virological Classification and Genetic Architecture

Canine distemper virus (CDV) is a highly pathogenic, enveloped, single-stranded negative-sense RNA virus belonging to the genus Morbillivirus within the family Paramyxoviridae, order Mononegavirales [3, 8, 20]. This taxonomic placement places CDV in close evolutionary relationship with other significant morbilliviruses, including the human measles virus (MeV) and the now-eradicated rinderpest virus of cattle, as well as phocine distemper virus (PDV) and cetacean morbilliviruses [3, 8, 26]. The virus is classified by the World Organisation for Animal Health (WOAH) as a notifiable pathogen due to its profound impact on both domestic animal health and wildlife conservation, and it is recognized globally as a multi-host pathogen of critical concern [5, 17, 45].

The CDV genome, approximately 15,690 nucleotides in length, encodes six structural proteins arranged in the canonical order 3′-N-P-M-F-H-L-5′: the nucleocapsid protein (N), phosphoprotein (P), matrix protein (M), fusion protein (F), hemagglutinin protein (H), and the large polymerase protein (L) [26, 45]. The P gene additionally encodes two non-structural proteins, C and V, through a process of RNA editing, which are involved in modulating the host interferon response [8]. Among these proteins, the hemagglutinin (H) protein is of paramount importance for viral tropism and host range determination, as it mediates attachment to cellular receptors [45]. The H protein is also the most genetically variable component of the virion, a feature that underpins the remarkable capacity of CDV to undergo cross-species transmission and adapt to novel hosts [12, 17, 45]. The fusion (F) protein facilitates subsequent membrane fusion and viral entry following H protein-receptor binding [22, 27, 35].

1.2 Molecular Mechanisms of Host Tropism and Receptor Usage

The capacity of CDV to infect an extraordinarily broad range of mammalian species, spanning at least six orders and over 20 families, including Carnivora, Primates, Rodentia, Artiodactyla, Pilosa, and Cetacea, is a defining characteristic that distinguishes it from many other viral pathogens [17, 20, 45]. This promiscuity is fundamentally dictated by the interaction of the viral H protein with host cellular receptors. The primary receptor for wild-type CDV strains is the signaling lymphocytic activation molecule (SLAM, also known as CD150), which is expressed on activated immune cells, including lymphocytes, macrophages, and dendritic cells [35, 45, 47]. This interaction facilitates the initial lymphotropism of CDV, leading to profound immunosuppression that is a hallmark of the disease [36]. A second critical receptor is nectin-4 (also known as PVRL4), an adherens junction protein expressed on the basolateral surface of epithelial cells in the respiratory, gastrointestinal, and urinary tracts [12, 35, 45]. Engagement of nectin-4 enables the virus to spread to epithelial surfaces, facilitating viral shedding and horizontal transmission [45].

Crucially, specific amino acid substitutions within the H protein, particularly in the SLAM-binding region, have been linked to host range expansion [12, 28]. A landmark finding is that CDV strains encoding a histidine at position 549 (549H) are predominantly associated with infections in domestic dogs and other canids, whereas a tyrosine at this residue (549Y) is significantly more prevalent in strains infecting non-canid wildlife hosts, including large felids, mustelids, and procyonids [4, 9, 12, 28]. For example, analysis of CDV strains from South African wildlife revealed that all non-canid strains (e.g., from lions and leopards) carried the 549Y mutation, while canid strains often carried 549H [12]. Similarly, a study on golden jackals in Serbia identified the Y549 mutation, suggesting adaptation to a wild canid host [28]. Furthermore, a substitution from isoleucine to valine or other residues at position 519 (e.g., 519I) has been identified as another marker of adaptation to non-canid species, particularly in large felids and mustelids [9, 12]. The 519I/549H combination was notably observed in a Malayan tiger, underscoring the virus's ongoing adaptation to novel carnivore hosts [9]. Recent work has also identified low-density lipoprotein receptor-related protein 6 (LRP6) as a functional entry receptor for the attenuated Onderstepoort vaccine strain (CDV-OP), though its role in wild-type virus entry remains under investigation [35].

1.3 Global Lineage Diversity and Phylogeography

Phylogenetic analysis of the complete H gene has become the gold standard for classifying CDV strains into distinct genetic lineages, or genotypes [12, 42, 45]. To date, at least 18 major lineages have been described globally, with new lineages continuing to emerge, particularly in wildlife reservoirs [42, 43]. This genetic diversity is driven by the error-prone nature of the RNA-dependent RNA polymerase, which generates a high mutation rate, coupled with selective pressures imposed by varying host immune systems and ecological niches [45, 50]. The major recognized lineages include:

1.3.1 European Lineages The European continent harbors a complex of co-circulating lineages. The Europe/South America-1 lineage (also known as EU1 or Europe-1) is one of the most widespread, historically associated with domestic dogs but repeatedly identified in wildlife across Europe, including red foxes, badgers, and wolves in Italy, Spain, and Croatia [4, 15, 34, 44]. A distinct subgroup, the European Wildlife lineage (also termed Europe Wildlife 2006-09), emerged in the Alpine region of Italy around 2006 and has been characterized by enhanced virulence and an expanded host range, causing significant mortality in red foxes, badgers, and pine martens [4, 15, 44, 49]. This lineage has been linked to a major multi-host epidemic wave that spread across the Italian Alps and into neighboring regions, demonstrating a capacity for long-distance dispersal and sustained transmission within wildlife populations [15]. The Arctic lineage represents another significant European clade, originally described in Arctic canids but now widely distributed across Europe, including Italy, Serbia, and Denmark [1, 28, 39]. In Italy, the Arctic lineage was detected in a badger and in dogs, indicating that this lineage is now established in temperate wildlife populations [1]. Phylogenetic analyses of CDV in the Czech Republic identified both the European and European-Wildlife lineages circulating in red foxes, raccoons, and stone martens, illustrating the co-existence of multiple lineages within a single geographic region [24].

1.3.2 American Lineages North America exhibits a highly dynamic and diverse CDV landscape. The America-1 lineage includes the historically dominant vaccine strains (e.g., Onderstepoort and Snyder Hill) but is now rarely detected in field samples [43, 46]. Instead, contemporary strains belong to more recently emerged lineages, including America-2 (now considered potentially paraphyletic), America-3 (Edomex), America-4, and America-5 [32, 43, 46, 48]. The America-4 lineage has emerged as a particularly important strain in the southeastern United States, where it has been associated with fatal outbreaks in both domestic dogs and a wide range of wildlife, including raccoons, gray foxes, and even non-carnivore species like Linnaeus’s two-toed sloths [32, 48]. A novel clade, the New England-1 lineage, was identified in mesocarnivores (fishers, gray foxes, mink, and skunks) in Vermont and New Hampshire, distinct from other known lineages, suggesting localized viral maintenance and evolution in this region [33, 37]. In Canada, a previously undescribed lineage, designated Canada-1, was found to be the predominant lineage circulating in raccoons and other wildlife in Ontario, highlighting the potential for cryptic viral diversity even in well-studied regions [46]. Phylogenetic analyses of CDV in the southeastern US have further revealed a distinct phylogeographic structure, with viral sequences clustering into eastern and western groups separated by the Mississippi River, indicating that large river systems may act as barriers to viral gene flow in certain wildlife populations [19].

South America is characterized by its own unique lineage dynamics. The South America-2 and South America-3 lineages circulate primarily in domestic dogs and wildlife in Brazil and Argentina [29]. More recently, the South America/North America-4 lineage has been documented in Chile, Colombia, and Brazil, indicating transcontinental movement of viral strains, likely via the movement of infected domestic dogs [21, 29]. In Brazil, CDV has also been detected in neotropical primates, such as the black-tufted marmoset and a Callithrix species co-infected with yellow fever virus, with sequences forming a divergent lineage related to EU1/South America-1 and South America-2 [16, 20].

1.3.3 Asian Lineages Asia is a recognized hotspot for CDV genetic diversity. The Asia-1 and Asia-2 lineages are widespread in domestic dogs across China, India, and Southeast Asia [9, 10, 30]. The Asia-4 lineage has been identified in dogs and wildlife in Thailand, including a fatal outbreak in wild-caught civets, and in Mongolia [30, 47]. Codon usage analysis of the Asia-4 H gene from the civet outbreak suggested that the virus had undergone initial adaptation to the civet host, underscoring the evolutionary plasticity of CDV [47]. The Asia-5 lineage is prevalent in Nepal and India, where it has been found in domestic dogs and has spilled over into leopards, causing fatal neurologic disease [10, 13]. Crucially, a novel Asia-6 lineage was recently identified from red pandas in China, showing a deep genetic divergence (>4.6% at the nucleotide level) from all previously recognized lineages, demonstrating that significant undiscovered viral diversity still exists in wildlife populations [42]. Northeast India, part of the Indo-Burma Biodiversity Hotspot, represents a potential convergence zone for CDV lineages, with the co-circulation of Asia-1 and Asia-5 strains in both domestic dogs and a wild jackal, emphasizing the role of this region as a corridor for viral exchange and spillover [10].

1.3.4 African and Other Lineages In Africa, CDV strains from wild carnivores, including lions, leopards, and African wild dogs, predominantly cluster within the Southern African lineage [12, 45]. Phylogenetic analysis of South African wildlife isolates revealed two possible co-circulating sub-genotypes corresponding to northern and southern regions of the country, and all non-canid strains possessed the 519I/549H combination, reinforcing the role of these mutations in wildlife adaptation [12]. A novel lineage, Africa-2, has also been proposed from recent isolates [45]. The Caspian Sea lineage has been reported from seals and represents a unique aquatic-adapted clade [8].

1.4 Epidemiological Implications of Lineage Diversity for Wildlife Conservation

The remarkable genetic and antigenic heterogeneity of CDV lineages has profound implications for wildlife conservation epidemiology. The emergence of novel strains, such as the America-4 and Arctic lineages, poses a direct threat to naive wildlife populations, many of which are already endangered or have small population sizes [5, 7, 9, 17, 25]. The ability of CDV to establish self-sustaining transmission cycles within wildlife communities, independent of domestic dog populations, complicates control efforts [17, 45, 49]. This phenomenon is evident in the Alpine region, where the Europe Wildlife lineage has persisted in a multi-host system dominated by red foxes, badgers, and martens, acting as a true wildlife reservoir [49]. Similarly, in the United States, raccoons (Procyon lotor) are recognized as a primary reservoir that maintains viral circulation and periodically spills over into other wildlife and domestic animals [14, 31, 38]. The introduction of novel lineages into areas with existing endemic strains can lead to competitive displacement and altered disease dynamics, as was suggested by the sequential appearance of two distinct epidemic waves in the Italian Alps [15].

Surveillance studies consistently report high seroprevalence and infection rates across diverse wildlife taxa. In northwestern Italy, prevalence rates of 60% in red foxes, 47% in badgers, and 51% in beech martens have been documented [2]. Similarly, in the Czech Republic, 28% of red foxes tested positive for CDV RNA [24]. In the United States, seropositivity rates of 25.4% in coyotes and 36.5% in red foxes have been reported in Pennsylvania [11], while a longitudinal study in Ontario, Canada, demonstrated that 58.5% of mesocarnivores submitted for diagnostic testing were CDV-positive [19]. These data underscore the extensive and ongoing circulation of CDV in wild carnivore guilds globally. The impact on endangered species is particularly alarming, with documented mortality events in Malayan tigers [9, 23], Javan leopards [41], Galapagos sea lions [18, 40], and African wild dogs [6]. Therefore, understanding the taxonomic and phylogenetic structure of CDV is not merely an academic exercise but a fundamental prerequisite for developing effective, lineage-informed diagnostic tools, vaccines, and surveillance strategies aimed at mitigating the threat of this multi-host pathogen to global biodiversity.

Molecular Pathogenesis of Canine Distemper Virus in Wild Carnivorans

Canine distemper virus (CDV), a negative-sense, single-stranded RNA virus of the genus Morbillivirus within the family Paramyxoviridae, represents one of the most significant multi-host pathogens affecting wild carnivoran populations globally [1, 3, 56]. The molecular pathogenesis of CDV in these species is a complex, multifactorial process governed by viral genetic determinants, host receptor dynamics, and intricate immune evasion strategies. This virus, closely related to the human measles virus and the now-eradicated rinderpest virus of cattle, exhibits a remarkable propensity for cross-species transmission, a characteristic that underpins its status as a major conservation threat [3, 17, 45]. Understanding the molecular underpinnings of CDV infection, from initial cellular entry to systemic dissemination and immunopathology, is critical for predicting spillover events and developing effective intervention strategies in wildlife.

Receptor-Mediated Entry and Host Range Expansion

The molecular basis of CDV's expansive host range, which now encompasses over 20 families within the order Carnivora and extends to non-human primates, pinnipeds, and even ungulates, is fundamentally rooted in the virus's interaction with host cell receptors [9, 17, 45]. The primary cellular receptor for wild-type CDV is the signaling lymphocytic activation molecule (SLAM, also known as CD150), expressed on activated lymphocytes, macrophages, and dendritic cells [35, 45]. The high degree of conservation of SLAM orthologs across mammalian species is a key factor facilitating viral tropism for immune cells, leading to the profound immunosuppression characteristic of distemper. The viral hemagglutinin (H) protein, a type II transmembrane glycoprotein, is the principal determinant of receptor specificity and is responsible for attachment to SLAM [12, 26, 45]. This attachment triggers a conformational change in the fusion (F) protein, mediating the fusion of the viral envelope with the host cell membrane.

A second, functionally distinct receptor, nectin-4 (also known as PVRL4), is utilized by CDV to infect epithelial cells of the respiratory, gastrointestinal, and urogenital tracts [35]. Nectin-4 is an adherens junction protein expressed on the basolateral surface of epithelial cells and is accessed by the virus during the later stages of infection, facilitating viral shedding and horizontal transmission. The sequential use of SLAM (for initial lymphotropism and dissemination) and nectin-4 (for epitheliotropism and shedding) represents a conserved pathogenesis strategy shared among morbilliviruses.

Beyond these canonical receptors, the discovery of low-density lipoprotein receptor-related protein 6 (LRP6) as a functional entry receptor for the attenuated Onderstepoort vaccine strain (CDV-OP) has expanded our understanding of viral entry mechanisms [35]. CRISPR/Cas9 knockout screens identified LRP6 as essential for CDV-OP infection in SLAM/nectin-4-negative cancer cell lines [35]. While LRP6 likely does not serve as a primary receptor for wild-type CDV in natural hosts, its identification highlights the molecular plasticity of CDV entry and may have implications for understanding cell-culture adaptation and oncolytic virotherapy, though not directly for pathogenesis in wild carnivorans.

Signature Mutations and Adaptive Evolution in the H Protein

The H gene is the most variable region of the CDV genome, driven by selective pressure from host immune responses and the need to adapt to new receptor orthologs. Phylogenetic analyses have delineated at least 18 distinct CDV lineages globally, including Europe/South America-1, Arctic-like, European Wildlife, Asia-1 through Asia-6, and several America lineages [4, 12, 42, 46]. Crucially, specific amino acid substitutions within the H protein's SLAM-binding region are strongly associated with host adaptation and virulence. The most extensively documented of these is the mutation at residue 549, where a tyrosine-to-histidine substitution (Y549H) is consistently identified in CDV strains infecting non-canid wildlife species [4, 9, 12, 28, 39].

The Y549H substitution has profound implications for molecular pathogenesis. In canid-adapted strains, residue 549 is typically tyrosine (Y). However, in strains isolated from mustelids, procyonids, felids, ursids, and other non-canid hosts, the presence of histidine (H) at position 549 is widespread and is hypothesized to confer enhanced binding affinity to the SLAM orthologs of these species [4, 12, 28]. For instance, a study characterizing CDV from a Malayan tiger (Panthera tigris jacksoni) revealed both 549H and 519I mutations in the H protein, indicative of adaptation to a non-canid host [9]. Similarly, CDV strains from South African wildlife, including non-canid species, exhibited the 519I/549H combination, whereas canid strains more commonly showed 519V/549Y [12]. This pattern supports a model where these mutations are not merely phylogenetic markers but functional adaptations that facilitate cross-species spillover and subsequent adaptation. The Y549H mutation has also been linked to increased virulence; a study of CDV outbreaks in northern Italy reported this mutation in all sequences collected from wildlife, associating it with heightened pathogenicity [4].

Furthermore, mutations at residue 530 of the H protein appear to be more conserved, with asparagine (N) being the predominant residue across host species, suggesting a critical structural or functional role [12]. Other lineage-specific substitutions in the H protein's receptor-binding domain and variations in N-glycosylation sites, as observed in CDV strains from Northeast India, further modulate antigenicity and receptor interactions, contributing to the virus's ability to evade vaccine-induced immunity and persist in diverse host populations [10, 26].

Early Events: Immunosuppression and Immune Evasion

Following entry via the respiratory or oronasal route, CDV initially replicates in local lymphoid tissues, including tonsils and bronchial lymph nodes. This primary replication phase is orchestrated by the virus's tropism for SLAM-expressing immune cells. The ensuing viremia disseminates the virus to secondary lymphoid organs, bone marrow, and the systemic lymphatic system, resulting in profound lymphopenia and immunosuppression [36]. The molecular pathogenesis of this immunosuppression is multi-pronged.

CDV infection of lymphocytes and dendritic cells leads to direct cytolysis, cellular depletion, and disruption of antigen presentation. Critically, CDV has been shown to induce an anti-inflammatory cytokine environment early in infection. An ex vivo study using precision-cut lung slices (PCLSs) infected with CDV strain R252 demonstrated elevated levels of interleukin-10 (IL-10) and transforming growth factor-beta (TGF-β) as early as one day post-infection [36]. These cytokines are potent suppressors of cellular immunity and antiviral effector functions. This early shift towards an anti-inflammatory milieu likely creates a permissive state for unchecked viral replication, curtailing the development of a robust adaptive immune response. Additionally, the virus impairs ciliary activity in the respiratory epithelium, compromising mucociliary clearance and predisposing the host to secondary bacterial infections, a common cause of morbidity and mortality in distemper [36].

Emerging evidence suggests that CDV may induce immune amnesia, a phenomenon well-documented for measles virus. A longitudinal serologic study in wild raccoons (Procyon lotor) found that CDV exposure was associated with a subsequent decrease in antibody titers against canine parvovirus, indicating that CDV infection may deplete immunological memory [38]. This is likely mediated by the virus's ability to infect and deplete memory B and T lymphocytes and long-lived plasma cells, which express SLAM. Such immune amnesia could have cascading effects on population-level immunity, potentially increasing susceptibility to other pathogens like rabies virus, and complicating wildlife vaccination efforts.

Tissue Tropism, Pantropic Infection, and Neurologic Disease

The eventual invasion of epithelial cells via nectin-4 leads to viral shedding and the characteristic clinical signs of respiratory, gastrointestinal, and urogenital involvement. In severe cases, CDV exhibits a pantropic distribution, with viral antigen detectable in a wide array of tissues. In a fatal outbreak among black-tufted marmosets (Callithrix penicillata) in Brazil, CDV genomic sequences and antigens were detected in multiple organs, including the brain, lungs, liver, spleen, and skin, confirming a highly disseminated, pantropic infection [20]. Similarly, in Malayan tigers, CDV antigens were localized in the lung, liver, kidney, and stomach tissues [9].

The neurotropism of CDV is a hallmark of its pathogenesis, often leading to fatal demyelinating encephalitis. The virus gains access to the central nervous system (CNS) via infected lymphocytes crossing the blood-brain barrier (the "Trojan horse" mechanism) or, more controversially, by direct infection of endothelial cells. Within the CNS, CDV infects neurons, astrocytes, microglia, and oligodendrocytes. In sea otters (Enhydra lutris), CDV infection resulted in severe lymphoplasmacytic meningoencephalitis with neuronal necrosis, satellitosis, and demyelination, mirroring the pathology seen in dogs [52]. In captive tigers, a novel and debilitating clinical outcome linked to CDV infection is laryngeal paralysis, which developed in nearly 50% of infected animals [53]. This condition likely arises from viral damage to peripheral nerves controlling the larynx, specifically the recurrent laryngeal nerve, causing stridor and respiratory distress. Histologic findings in these tigers confirmed laryngeal inflammation and neurogenic atrophy, expanding the known spectrum of CDV-induced neurologic disease in large felids [53].

The molecular switch that triggers the transition from acute infection to persistent CNS infection is poorly understood but is likely influenced by host immune status (e.g., incomplete immune response) and viral strain-specific factors. The high frequency of Y549H and associated mutations in strains causing severe neurologic disease in wildlife underscores the role of H protein adaptation in driving distinct pathogenic outcomes.

Coinfections and Synergistic Pathogenesis

In the complex ecology of wildlife, CDV rarely acts in isolation. Coinfections with other pathogens can profoundly alter the molecular pathogenesis of CDV. A significant study found concurrent CDV infection in 5.6% of animals already infected with rabies virus [51]. This co-morbidity has critical diagnostic and public health implications, as CDV can present with neurologic signs indistinguishable from rabies [51, 54]. Whether CDV infection potentiates rabies virus entry or replication in the CNS is not known, but the synergistic immunosuppression could be a factor.

Other notable coinfections include CDV with canine parvovirus (CPV-2b) in an Arctic wolf, where combined lymphoid and hematopoietic necrosis was observed [55]. CDV has also been found co-infecting gray foxes with Listeria monocytogenes and skunk adenovirus-1, suggesting that CDV-induced immunosuppression may predispose animals to secondary bacterial and viral infections [33]. In neotropical primates, CDV coinfection with yellow fever virus has been documented, raising concerns about the interplay of these two pathogens in endangered species [16]. These coinfections highlight that the molecular pathogenesis of CDV in wildlife must be considered within a broader framework of host-pathogen interactions and environmental stressors.

Epidemiology and Cross-Species Transmission Dynamics in Wildlife Populations

Canine distemper virus (CDV) represents one of the most formidable multi-host pathogens confronting contemporary wildlife conservation and veterinary public health. As a single-stranded RNA virus of the genus Morbillivirus within the Paramyxoviridae family, CDV shares a close phylogenetic relationship with the human measles virus and the now-eradicated rinderpest virus of cattle, a lineage that underscores its capacity for host switching and pandemic potential [3, 45]. The virus is recognized by the World Organisation for Animal Health (WOAH) as a significant transboundary pathogen, and its epidemiology is increasingly characterized by a shift from a primarily canine-centric disease to a pantropic, multi-species infection with complex maintenance cycles that defy simple reservoir-host paradigms [17, 45]. Understanding the transmission dynamics within wildlife populations is not merely an academic exercise; it is a prerequisite for predicting spillover events, mitigating conservation threats to endangered species, and informing vaccination strategies at the domestic-wildlife interface.

Global Prevalence and Host Range in Wild Populations

The epidemiological landscape of CDV in wildlife is marked by an extraordinary breadth of susceptible hosts, spanning at least six orders and over 20 families of mammals, including Canidae, Felidae, Mustelidae, Procyonidae, Ursidae, Viverridae, Hyaenidae, and even non-carnivorous taxa such as non-human primates, artiodactyls, and marsupials [45, 46]. Passive surveillance data from the Southeastern Cooperative Wildlife Disease Study in the United States, spanning 1975 to 2019, documented 964 CDV-positive cases across 17 states, encompassing raccoons (Procyon lotor), gray foxes (Urocyon cinereoargenteus), striped skunks (Mephitis mephitis), coyotes (Canis latrans), red foxes (Vulpes vulpes), gray wolves (Canis lupus), American black bears (Ursus americanus), American mink (Neovison vison), and long-tailed weasels (Mustela frenata) [14]. This dataset revealed that raccoons and gray foxes accounted for the majority of cases (67% and 26%, respectively), establishing these mesocarnivores as sentinel species for CDV activity in North America [14].

In Europe, prevalence rates vary dramatically by region and host species. A comprehensive study in northwestern Italy (Aosta Valley) during epidemic waves between 2015 and 2020 reported prevalence rates of 60% in red foxes (n=296), 47% in Eurasian badgers (Meles meles, n=103), 51% in beech martens (Martes foina, n=51), and 14% in wolves (Canis lupus, n=157) [2]. In southwestern Europe (Asturias, Spain), a 2020–2021 outbreak yielded 19.51% positivity across eight wild carnivore species, with a retrospective serosurvey of 684 badgers from 2008–2020 revealing a 43.4% seroprevalence, indicating long-term, though fluctuating, viral circulation [3]. In the Czech Republic, a national surveillance program (2012–2020) detected CDV in 18% of 412 wild animals, with red foxes showing the highest positivity (28%), followed by raccoons (43%), stone martens (10%), and pine martens (20%) [24]. In southern Italy (Campania region), recent surveillance (2022–2024) detected CDV RNA in 10.3% of 136 wild animals, including badgers, foxes, wolves, and martens, with a complete genome belonging to the Arctic clade [1].

In Africa, a systematic review of CDV in wildlife from 1978–2021 identified outbreaks in six countries with mortality rates ranging from 30% to 94% across 11 susceptible wildlife species, 64% of which are classified as threatened by the International Union for Conservation of Nature (IUCN) [6]. Critically, 61% of studies investigating the role of domestic dogs concluded that dogs acted as either reservoirs or sources of CDV for wildlife, although no study confirmed transmission direction due to a lack of matched molecular epidemiology [6]. In Asia, the emergence of CDV in apex predators has been particularly alarming. The first detection in a Malayan tiger (Panthera tigris jacksoni) in Malaysia in 2019, with the strain belonging to the Asia-1 clade and harboring the Y549H mutation associated with non-canid adaptation, underscores the threat to already critically endangered felids [9]. Similarly, fatal neurologic disease in leopards (Panthera pardus) in Nepal was linked to the Asia-5 lineage, with molecular evidence suggesting acquisition through dog predation [13]. In Brazil, a lethal outbreak among free-ranging black-tufted marmosets (Callithrix penicillata) in urban parks of Belo Horizonte demonstrated that CDV can cause pantropic, fatal disease in neotropical primates, with viral antigen detected in multiple organs and coinfection with gammaherpesvirus 3 noted in several animals [20]. This event, combined with the first report of natural CDV and yellow fever virus coinfection in a Callithrix primate [16], highlights the synergistic potential of emerging pathogens in novel hosts.

Molecular Mechanisms Driving Cross-Species Transmission

The capacity for CDV to jump species barriers is fundamentally encoded in its hemagglutinin (H) protein, which mediates attachment to host cellular receptors, primarily the signaling lymphocytic activation molecule (SLAM) on immune cells and nectin-4 on epithelial cells [45, 47]. The H gene exhibits the highest genetic variability within the CDV genome, and this diversity is the engine of host range expansion [26, 45]. Phylogenetic analyses have classified CDV strains into at least 18 major genetic lineages based on H gene sequences, with new lineages continually emerging, such as the Asia-6 lineage identified from red pandas in China [42].

A critical molecular signature of cross-species adaptation involves amino acid substitutions at key positions within the SLAM-binding region. The Y549H mutation in the H protein has been repeatedly associated with infection in non-canid species. In South Africa, a study of CDV in four wildlife species found that all non-canid strains (including those from lions, leopards, and wild dogs) presented the combination 519I/549H, supporting the notion that this motif enhances adaptation to non-canid hosts [12]. Similarly, in golden jackals from Serbia, all sequenced strains displayed a tyrosine (Y) at position 549 rather than the histidine (H) typically found in domestic dog strains, suggesting that the jackal population maintains a wildlife-adapted viral variant [28]. In Malayan tigers, the Y549H mutation was again observed [9], and in red foxes from Italy, the Y549H mutation was present in all sequences collected from the European Wildlife lineage [4]. The convergent evolution toward this substitution in diverse geographic regions and host families indicates strong positive selection for this residue in non-canid hosts.

Beyond receptor-binding residues, codon usage bias also plays a role in host adaptation. A study of CDV Asia-4 lineage in a fatal outbreak among wild-caught civets in Thailand revealed that the codon usage pattern of the H gene was more related to the codon usage of civets than of dogs, suggesting that the virus had initially adapted its translational efficiency to the new host [47]. This selective bias toward A/U-ended codons reflects a fundamental constraint on viral replication within a novel cellular environment. Furthermore, the discovery of low-density lipoprotein receptor-related protein 6 (LRP6) as a third entry receptor for attenuated CDV strains, such as the Onderstepoort vaccine strain, expands the current understanding of viral tropism and suggests that cell culture adaptation can uncover alternative entry pathways that may be relevant for oncolytic virotherapy but also raise questions about the potential for vaccine strains to acquire enhanced tropism for non-canid cells [35].

Spatial and Temporal Dynamics of Transmission

The transmission of CDV in wildlife populations is not random but is structured by landscape features, host density, anthropogenic land use, and seasonal fluctuations. Passive surveillance data from the southeastern United States demonstrated that CDV cases in raccoons and gray foxes were significantly more likely to occur during the breeding season (January–March), a period characterized by increased intraspecific contact and the influx of susceptible juveniles [14]. Spatial clustering analysis revealed that cases were more likely to occur in areas of medium to high human population density, with fewer cases in both the most densely populated urban cores and the most sparsely populated rural areas [14]. This pattern was especially pronounced for raccoons, which achieve their highest densities in suburban landscapes where supplemental food resources (e.g., garbage, pet food) and suitable denning habitat are abundant [14]. A subsequent study across 13 southeastern states confirmed that surface imperviousness and precipitation were significant positive explanatory variables for CDV infection, while elevation had a significant negative association, effectively mapping high-risk zones onto human-modified landscapes [19].

In the Alpine region of Italy, phylogeographic analysis of the European Wildlife lineage over two epidemic waves (2006–2009 and 2011–2018) revealed distinct virus introductions with different diffusion rates and spatial distributions, suggesting that host population dynamics, rather than viral genetics alone, governed the spread [15]. The first wave exhibited rapid, widespread dissemination across the northeastern regions (Veneto, Trentino Alto Adige, Friuli Venezia Giulia), while the second wave was more spatially restricted, potentially reflecting changes in host immunity or population density [15]. The first documented spillover of this wild-adapted strain to an unvaccinated domestic dog in a rural area of Friuli Venezia Giulia underscores the bidirectional nature of the wildlife-domestic interface [15].

A novel approach using remote-sensing-derived NDVI entropy as a proxy for landscape fragmentation has been employed to model CDV risk in the Aosta Valley, Italy. The study found that CDV trends were strongly correlated with anomalies in NDVI entropy changes, which reflect the intensity of habitat fragmentation and, consequently, the potential for wildlife ecological corridors to facilitate contact among susceptible hosts [2]. This geospatial modeling approach, endorsed by the One Health framework, offers a predictive tool for identifying high-risk zones without requiring exhaustive field sampling, enabling targeted surveillance and preemptive management interventions [2].

In Ontario, Canada, longitudinal serologic studies in raccoons have provided critical insights into within-population dynamics. Juvenile raccoons were more likely to be seronegative from August to November, and the subsequent winter breeding season emerged as a high-risk period for CDV exposure due to increased intraspecific contact and the presence of a large cohort of susceptible juveniles [38]. Alarmingly, seropositive adult raccoons exhibited nondetectable antibody titers within 1 month to 1 year after infection, and preliminary evidence suggested that CDV exposure was associated with a decrease in parvovirus titer, raising the possibility of virus-induced immune amnesia analogous to that described for measles virus [38]. If confirmed, this phenomenon would have profound implications for population-level immunity and the management of co-circulating pathogens such as rabies virus.

The Domestic Dog-Wildlife Interface and Maintenance Hosts

The role of the domestic dog (Canis familiaris) as the primary reservoir for CDV has been increasingly challenged by evidence of self-sustaining transmission cycles within wildlife, independent of canine input. A meta-analysis of 53 studies encompassing 11,527 dogs found that unvaccinated dogs and free-roaming dogs were significantly more likely to be CDV-positive, with pooled molecular and serological frequencies of 33% and 46%, respectively [57]. However, the persistence of CDV in wildlife populations, even in the absence of clinical disease in domestic dogs, indicates that mesocarnivores such as raccoons, red foxes, and badgers can act as true maintenance hosts [6, 17, 45].

In the United States, at least seven distinct CDV lineages (America-2, America-3, America-4, America-5, and two additional clades) are circulating in wildlife, and these lineages are genetically distinct from the vaccine strains used in domestic dogs [32, 43]. The emergence of a new strain in 2011, which became the predominant strain in clinical submissions from multiple states, including fully vaccinated adult dogs, suggests that wildlife reservoirs can drive the evolution of vaccine-escape variants [32]. In Canada, phylogenetic analysis of CDV from ten wild and domestic species in Ontario identified a novel dominant lineage (Canada-1) circulating in wildlife, as well as multiple co-circulating lineages, with raccoons appearing to play a key role in viral maintenance and transmission [46]. The importation of a South American CDV lineage into Ontario via an infected dog further demonstrates the role of animal movement in introducing novel genetic diversity into wildlife populations [46].

In Africa, the presumption that domestic dogs are the sole source of CDV for wildlife is complicated by the fact that many African wild dogs (Lycaon pictus) and lions (Panthera leo) have been infected by strains that are genetically distinct from those circulating in sympatric domestic dogs, suggesting independent wildlife cycles [6]. A systematic review found that 61% of studies concluded dogs acted as reservoirs, but 17% did not identify dogs as a source, and 22% were uncertain due to a lack of matched sampling [6]. This ambiguity underscores the need for integrated, cross-species genomic surveillance to definitively trace transmission pathways.

Spillover into Novel and Endangered Hosts

The consequences of CDV spillover into naive or endangered populations can be catastrophic. The infection of Galapagos sea lions (Zalophus wollebaeki) with CDV, first detected in 2010, has been confirmed by seroconversion data showing a significant increase in neutralizing antibodies from 19.6% in 2016 to 53.1% in 2017 [18]. This ongoing circulation in a pinniped population, tens of kilometers from mainland reservoirs, highlights the capacity for CDV to bridge marine and terrestrial ecosystems, likely through anthropogenic introduction via domestic dogs on the islands [18, 40]. The 2019 CDV outbreak in domestic dogs in the Galapagos, which had a 74.4% positivity rate, represents a persistent threat to the endangered sea lion despite policies for dog population control and vaccination [40].

In the aquatic realm, canine distemper was documented in sea otters (Enhydra lutris) in Washington State, USA, between 2000 and 2010. Histologic findings included severe lymphoplasmacytic meningoencephalitis with intranuclear and intracytoplasmic inclusion bodies in neurons and glial cells, mirroring the neurologic form of CDV in domestic dogs [52]. The seroprevalence in live-captured otters reached 80% in 2001–2002, suggesting a recent epizootic event [52]. The detection of CDV in a neotropical primate (Callithrix sp.) in Brazil, coinfected with yellow fever virus, represents a novel host jump and raises concerns about the role of CDV as a confounding factor in yellow fever surveillance and primate conservation [16, 20].

The infection of Linnaeus’s 2-toed sloths (Choloepus didactylus) in a private zoo in Tennessee with the American-4 lineage resulted in fatal disease in five adult animals, characterized by hepatic necrosis, lymphoid depletion, and bronchointerstitial pneumonia, without central nervous system involvement [48]. This outbreak, linked to a strain prevalent in eastern Tennessee wildlife, underscores the vulnerability of phylogenetically distant xenarthrans to CDV and the role of zoological collections as sentinels for circulating wildlife strains [48]. Similarly, an outbreak in captive tigers in Thailand resulted in cumulative morbidity and mortality rates that were relatively high, with 50% of survivors developing laryngeal paralysis at a median of 314 days post-infection, a novel clinical manifestation of chronic CDV infection in large felids [53]. A quantitative risk assessment for CDV introduction into captive tiger facilities in Thailand identified contaminated human hands, followed by other CDV-infected wild animals and contaminated equipment, as the most influential pathways, and demonstrated that full implementation of biosecurity measures could reduce risk by 89.6% [7].

The detection of CDV RNA in common tree shrews (Tupaia glis) in Malaysia, with 99.50% nucleotide similarity to the strain that killed a Malayan tiger in the same region, provides the first molecular evidence that small mammals may act as overlooked reservoir hosts, facilitating viral maintenance and spillover between domestic animals and apex predators [23]. This finding challenges the conventional view that only carnivores are relevant to CDV epidemiology and suggests that the viral host range may be broader than currently appreciated.

Conclusion of Section (Omitted per Instructions)

The subsequent sections of this article will address the diagnostic approaches, pathological manifestations, and intervention strategies required to manage CDV in wildlife.

Diagnostic Approaches for Canine Distemper Virus in Wildlife: Molecular and Serological Methods

The accurate and timely diagnosis of canine distemper virus (CDV) infection in wildlife populations presents a formidable challenge, fundamentally distinct from diagnostics in domestic animals. The vast array of potential host species, the frequent lack of ante-mortem clinical history, the rapid autolysis of field carcasses, and the logistical constraints of remote sampling necessitate a multi-pronged diagnostic strategy. Within the framework of global health security, the World Organisation for Animal Health (WOAH) recognizes CDV as a significant pathogen requiring robust surveillance, particularly given its potential to impact endangered species. The diagnostic arsenal for CDV in wildlife is bifurcated into two principal, complementary domains: molecular detection of viral nucleic acids, which confirms active, often acute infection, and serological detection of host antibodies, which provides evidence of past exposure or immunological history. The integration of these methodologies, coupled with an understanding of their inherent limitations and species-specific validations, is paramount for epidemiological surveillance, outbreak investigation, and the implementation of effective conservation strategies.

Molecular Detection and Genomic Characterization

Molecular diagnostics, particularly real-time reverse transcription polymerase chain reaction (RT-qPCR), have become the gold standard for confirming acute CDV infection in wildlife due to their unparalleled sensitivity, specificity, and speed. The cornerstone of these assays is the amplification of conserved regions of the CDV genome, most commonly the phosphoprotein (P) gene, which is involved in viral transcription and replication. The P gene is a preferred target because it is highly expressed and contains conserved regions across diverse CDV lineages, enabling the design of pan-genotypic assays capable of detecting a broad spectrum of circulating strains [2, 8]. A landmark study by Geiselhardt et al. (2022) established a validated, pan-genotypic, probe-based RT-qPCR assay targeting the P gene, demonstrating its utility across six distinct CDV genotypes and various sample matrices, including frozen tissues and formalin-fixed paraffin-embedded (FFPE) sections [8]. This assay's superior sensitivity compared to other published methods, particularly for the Asia-4 genotype, underscores its critical role in screening wildlife where novel or divergent genotypes may circulate.

The selection of the biological sample matrix is a critical determinant of diagnostic success. For post-mortem surveillance, tissues such as brain, lung, spleen, and lymph nodes are considered highly reliable due to the pantropic nature of CDV. Neurotropic strains often persist in the central nervous system (CNS) even after systemic clearance, making brain tissue a key target for detecting chronic neurological forms of distemper [3, 52]. In live animals, the choice of sample is dictated by the clinical stage of disease. Conjunctival, nasal, and rectal swabs are frequently employed, with studies indicating that rectal swabs may offer superior sensitivity for active viral shedding in both domestic and wild canids [44, 63]. The study by Ricci et al. (2021) in Italy found that rectal swabs were the most suitable sample for CDV diagnosis in live animals, with 81.82% positivity among tested individuals [44]. For species where invasive sampling is impractical, non-invasive methods such as fecal sample analysis have proven effective, as demonstrated by the detection of CDV RNA in fecal samples from a Javan leopard using RT-PCR targeting partial sequences of the nucleoprotein (N) and hemagglutinin (H) genes [41]. The rapid autolysis of field samples, however, necessitates careful handling and cold-chain preservation to maintain RNA integrity.

The application of RT-qPCR has been instrumental in revealing the true prevalence and epidemiological dynamics of CDV in wildlife. In a comprehensive surveillance study of Alpine wildlife in Italy (2013–2015), real-time PCR confirmed CDV circulation in 548 wild carnivores, including red foxes, badgers, and wolves, with the virus belonging to the Europe Wildlife 2006-09 subgroup [49]. Similarly, a large-scale study in the Czech Republic (2012–2020) detected CDV RNA in 18% of 412 tested animals, primarily red foxes and badgers, using real-time RT-PCR [24]. These molecular data are indispensable for constructing accurate spatial and temporal distribution maps and for identifying reservoir species. For instance, the high prevalence (60%) detected in red foxes in the Aosta Valley, Italy, via TaqMan RT-PCR, suggests that foxes act as a primary amplifying host for the virus in that ecosystem [2].

Beyond mere detection, molecular methods facilitate in-depth genetic and phylogenetic characterization, which is essential for tracing viral origins, monitoring the emergence of new lineages, and understanding cross-species transmission events. While the P gene is suitable for screening, the hemagglutinin (H) gene is the preferred target for phylogenetic analysis due to its high genetic variability. The H protein is the primary determinant of host tropism and viral entry, making its sequence a powerful tool for epidemiological investigations. Sanger sequencing of the H gene has been used to classify CDV strains into distinct geographical lineages (e.g., Europe-1, Arctic, Asia-1, America-4) and to identify specific amino acid substitutions associated with host adaptation and virulence [4, 13, 21, 28]. A critical mutation frequently identified in wildlife strains involves the substitution of histidine to tyrosine at residue 549 (Y549H), which is strongly associated with adaptation to non-canid hosts [4, 12, 28, 39]. Studies in South African wildlife and Serbian golden jackals have both identified the Y549H substitution, supporting the hypothesis that this mutation facilitates SLAM receptor binding in a broader range of species [12, 28]. Furthermore, the genetic characterization of CDV in a Malayan tiger in Malaysia revealed a 549H and 519I mutation, further underscoring the adaptability of the virus to large felids [9].

The phylogenetic analysis of H gene sequences has also been pivotal in identifying the emergence of novel lineages and tracking viral incursions across geographical boundaries. In the United States, sequencing of CDV from wildlife and domestic dogs has revealed the emergence of a distinct lineage (America-4) that is genetically divergent from vaccine strains and has been associated with significant disease in both populations [32, 43]. Similarly, research in the Southeast United States has identified a unique wildlife-specific clade in New England, isolated from fishers, gray foxes, and raccoons, which was not found in any domestic animals during the study period, suggesting a self-sustaining sylvatic cycle [33, 37]. The capacity to distinguish between these lineages through molecular characterization is not merely academic; it has profound implications for vaccine efficacy and risk assessment, as vaccine-induced immunity may be less effective against antigenically distinct field strains [32].

Serological Methods: Unveiling Exposure History and Population Immunity

While molecular techniques detect active infection, serological assays are the primary tool for assessing past exposure and population-level immunity. The detection of CDV-specific antibodies, primarily IgG, in wild carnivores provides a critical window into the historical circulation of the virus, even in the absence of clinical disease or active viral shedding. The two most common serological platforms employed in wildlife studies are the virus neutralization test (VNT) and the enzyme-linked immunosorbent assay (ELISA) , each with distinct advantages and limitations.

The VNT is considered the gold standard and the most specific serological test, as it measures the functional ability of antibodies to neutralize live virus. This assay is particularly valuable for determining protective immunity. Serosurveys of free-roaming dogs in Nepal's Chitwan National Park using VNT revealed an 80% seroprevalence, indicating high levels of past exposure and potential herd immunity, but also a persistent risk of transmission to threatened wildlife like the Bengal tiger [60]. The VNT has been successfully adapted for wildlife species, including the Galapagos sea lion, where it confirmed an increasing circulation of CDV between 2016 and 2017, posing a direct conservation threat to this endangered pinniped [18]. However, the VNT requires cell culture facilities, live virus, and is time-consuming and expensive, limiting its use in large-scale field surveillance.

ELISA-based assays offer a more practical, high-throughput alternative for field-based serosurveys. A critical challenge in wildlife serology is the lack of species-specific reagents (e.g., anti-canine IgG conjugates). To overcome this, researchers have employed Protein A or Protein A/G conjugates, which bind to the Fc region of IgG from a broad range of mammalian species. This universal approach was validated in a pivotal study on red foxes in Spain, where a modified ELISA using Protein A was compared against a commercial canine-specific ELISA [59]. The study demonstrated that Protein A provides good reactivity towards fox IgG and, after adjusting the cut-off point using a finite mixture model, yielded a seroprevalence of 57.1%, in moderate agreement with the commercial kit [59]. This methodological adaptation has been replicated across many studies, including serological surveys of raccoons, raccoon dogs, and wild boar in Japan, where a Protein A/G-based ELISA proved as reliable as the VNT for detecting CDV antibodies [61].

The application of ELISA-based serosurveys has provided critical insights into the long-term epidemiological patterns of CDV in wildlife communities. A large retrospective serosurvey of 684 Eurasian badgers in Spain, spanning 2008–2020, revealed a high average seroprevalence of 43.4%, indicating long-term but unstable viral circulation in this multi-host community [3]. This type of longitudinal data, which is only obtainable through consistent serological surveillance, is invaluable for predicting outbreak cycles and assessing the impact of management interventions. In North America, ELISA testing of coyotes and foxes in Pennsylvania demonstrated high exposure rates: 25.4% in coyotes, 36.5% in red foxes, and 12.5% in gray foxes, highlighting the ubiquitous nature of the virus in these synanthropic species [11]. The WOAH and various national wildlife health agencies rely on these serological data to inform risk assessments for pathogen spillover at the domestic-wildlife interface.

Despite their utility, serological methods have inherent limitations in wildlife contexts. The detection of antibodies from a single sample cannot distinguish between past resolved infection and persistent viral exposure. Furthermore, the duration of antibody persistence is variable and species-dependent. A longitudinal study in raccoons in Ontario demonstrated that seropositive adults could become seronegative within as little as one month to one year, indicating that antibody titers may wane rapidly and that single-point serosurveys may underestimate true exposure [38]. The interpretation of serological data must also account for maternally derived antibodies in juveniles, which can yield false positives for exposure [60, 65]. Concurrently, studies have shown that animals with high pre-existing antibody titers (from natural exposure) may not seroconvert strongly following vaccination, a phenomenon known as interference, which complicates the interpretation of vaccine efficacy trials in wildlife [65].

Integration and Strategic Considerations for Wildlife Surveillance

The most robust diagnostic framework for CDV in wildlife integrates both molecular and serological approaches in a context-dependent manner. The choice of diagnostic tool is dictated by the research or surveillance objective, the target species, and the available resources. For outbreak investigations with high mortality, RT-qPCR on tissue samples is the primary modality for confirming recent death due to CDV. The application of portable, point-of-care (POC) technologies, such as the Biomeme two3™ qPCR platform, is a significant advancement for field diagnostics. This system uses lyophilized, shelf-stable reagents and a handheld thermocycler, enabling real-time detection of CDV RNA in remote settings without the need for cold-chain transport of samples to centralized laboratories [54]. Although validation has shown slightly reduced sensitivity compared to lab-based methods, this technology dramatically accelerates the turnaround time for diagnosis, which is critical for rapid response to epizootics in endangered populations [54].

Conversely, for monitoring long-term viral circulation and population immunity in healthy or asymptomatic populations, serological surveys using ELISA or VNT are more appropriate. The combination of both methods within a single study provides the most comprehensive picture. For instance, research in red foxes simultaneously using RT-qPCR (20.8% prevalence) and ELISA (53.7% seroprevalence) allowed researchers to distinguish between active infections and historical exposure, providing a complete understanding of the infection dynamics at both individual and population levels [59]. Similarly, studies in the Brazilian Amazon have employed molecular and serological testing concurrently to demonstrate high exposure in domestic dogs and confirm spillover risk to wild carnivores, underlining the utility of a One Health surveillance approach [62].

The use of rapid immunochromatographic tests (ICT) or lateral flow devices offers an intermediate, field-deployable option for screening. While less sensitive than RT-qPCR or VNT, these tests can provide a rapid, point-of-care answer for clinical cases or in resource-limited settings. Studies in Nigeria and Romania have successfully used commercial CDV antigen test kits on fecal and brain samples from wildlife, reporting detection rates of over 50% in some cases [58, 64]. However, the sensitivity of these tests is often suboptimal compared to molecular methods, and they should be used for preliminary screening or in situations where laboratory access is impossible, rather than as a definitive diagnostic tool. The diagnostic strategy must always be tailored to the specific ecological and logistical constraints of the wildlife system under investigation, with a continuous emphasis on validating testing protocols for each novel host species to ensure accurate and reliable data for conservation and disease management.

Phylogenetic Diversity and Evolutionary Clades of Canine Distemper Virus in Wildlife

The phylogenetic architecture of canine distemper virus (CDV) in wildlife populations represents one of the most complex and rapidly evolving landscapes in contemporary virology. As a single-stranded, negative-sense RNA virus belonging to the genus Morbillivirus within the family Paramyxoviridae, CDV exhibits a mutation rate characteristic of RNA viruses, which, when coupled with its extraordinarily broad host range spanning at least six mammalian orders and over 20 families, creates a dynamic evolutionary milieu that challenges both our taxonomic frameworks and our disease management strategies [17, 45]. The World Organisation for Animal Health (WOAH) recognizes CDV as a pathogen of significant epizootic potential, and the genetic diversification of this virus in wildlife reservoirs has profound implications for conservation medicine, vaccine efficacy, and the prediction of future spillover events. The hemagglutinin (H) protein, which mediates receptor binding to signaling lymphocytic activation molecule (SLAM) and nectin-4 on host cells, is the primary driver of phylogenetic classification and host tropism, and it is upon this genetic locus that the majority of lineage designations are based [12, 45].

Global Lineage Architecture and the Expanding Phylogenetic Tree

The canonical classification of CDV into geographically and genetically distinct lineages has undergone substantial revision over the past decade. Historically, CDV strains were grouped into a handful of major lineages, but contemporary genomic surveillance has revealed a far more intricate tapestry. Currently, at least 18 to 20 distinct genetic lineages are recognized globally, including but not limited to: America-1 (vaccine-related strains), America-2, America-3 (Edomex), America-4, America-5, Europe-1 (also known as Europe/South America-1), European Wildlife, Arctic, Asia-1, Asia-2, Asia-3, Asia-4, Asia-5, Asia-6, Southern Africa, and South America-2, -3, and -4 [8, 42, 43]. The delineation of these lineages is typically based on a nucleotide divergence threshold of approximately 3–5% in the H gene, and the discovery of novel lineages continues at a remarkable pace, driven largely by expanded surveillance in previously undersampled wildlife populations and geographic regions [42].

The Asia-6 lineage, for instance, was identified from red pandas (Ailurus fulgens) in China, demonstrating a deep genetic distance exceeding 4.6% at the nucleotide level and 5.0% at the amino acid level from all other known lineages. Bayesian coalescent analysis suggested that this lineage diverged from the Asia-4 lineage as early as 1884, indicating a long and undetected evolutionary history in wildlife [42]. Similarly, the America-4 and America-5 lineages have been characterized as emerging strains circulating in both domestic dogs and wildlife in the United States, with the America-4 lineage (first detected in 2011) showing significant antigenic divergence from vaccine strains and being associated with outbreaks in fully vaccinated dogs [32, 43]. This lineage has been documented in a wide array of wildlife species, including raccoons (Procyon lotor), gray foxes (Urocyon cinereoargenteus), fishers (Martes pennanti), and even in a captive Arctic wolf (Canis lupus arctos) and Linnaeus’s two-toed sloths (Choloepus didactylus), underscoring its capacity for cross-species transmission and its establishment in sylvatic cycles [48, 55].

The European Wildlife Lineage and Alpine Dynamics

Europe presents a particularly instructive model for understanding the phylogenetic complexity of CDV in wildlife. The European continent is host to at least two major co-circulating lineages: the Europe-1 (Europe/South America-1) lineage and the European Wildlife lineage, with the latter being further subdivided into distinct temporal and spatial clusters [15, 44, 49]. The European Wildlife lineage, sometimes referred to as the “Europe Wildlife 2006-09” cluster, emerged as a highly virulent variant in the Alpine region of Italy, causing devastating outbreaks in red foxes (Vulpes vulpes), badgers (Meles meles), and other mesocarnivores beginning in 2006 [15, 49]. Phylogeographic analysis of strains from northeastern Italy revealed two distinct epidemic waves: the first from 2006 to 2009 and a second from 2011 to 2018. These waves were caused by genetically distinct viral introductions, each characterized by different diffusion rates and spatial distributions, suggesting a strong linkage between viral spread and host population dynamics [15]. The second wave, in particular, demonstrated a higher diffusion rate and broader geographic penetration, likely facilitated by the high density and mobility of red fox populations in the Alpine region [15, 49].

Critically, the European Wildlife lineage has been shown to possess specific amino acid signatures in the H protein that distinguish it from other Europe-1 strains. These include mutations at key residues within the SLAM-binding region, which may enhance binding affinity to non-canine SLAM receptors, thereby facilitating infection of a broader range of host species [44, 49]. This lineage has been detected in a remarkable diversity of hosts, including wolves (Canis lupus), stone martens (Martes foina), pine martens (Martes martes), polecats (Mustela putorius), and even Eurasian otters (Lutra lutra), indicating a true multi-host pathogen system [3, 24, 66]. In the Czech Republic, a comprehensive survey of 412 wild animals from 2012 to 2020 revealed that 74 (18%) were CDV-positive, with the vast majority of sequenced strains belonging to the European lineage, while a smaller subset clustered with the European Wildlife lineage [24]. This co-circulation of multiple lineages within a single geographic region and across multiple host species highlights the complex evolutionary dynamics at play.

Arctic Lineage: A High-Latitude Specialist with Global Reach

The Arctic lineage of CDV represents a fascinating case of viral adaptation to extreme environments and specific host populations. Initially characterized from isolates in the Arctic regions of Canada, Greenland, and Russia, this lineage has since been detected in a surprisingly wide geographic range, including Italy, Serbia, and other parts of Europe [1, 28, 44]. The detection of an Arctic lineage strain in a badger from southern Italy in 2022–2024, as reported by Alfano et al. [1], demonstrates that this lineage is not confined to high-latitude ecosystems but can become established in temperate wildlife populations. Phylogenetic analysis of the complete genome from this Italian badger strain confirmed its placement within the Arctic clade, showing high similarity to previous Arctic strains identified in dogs and badgers in Italy [1]. This suggests a sustained circulation of the Arctic lineage in European wildlife, possibly maintained through a combination of dog-to-wildlife spillover and subsequent wildlife-to-wildlife transmission.

In Serbia, molecular characterization of the H gene from golden jackals (Canis aureus) revealed that all sequenced strains clustered within the Arctic lineage [28]. Notably, these Serbian jackal strains possessed a tyrosine (Y) at position 549 of the H protein, a mutation that is commonly associated with wildlife hosts and is thought to enhance adaptation to non-canine species. In contrast, domestic dog strains typically harbor a histidine (H) at this position [12, 28]. The Y549H substitution has been extensively studied and is considered a key molecular marker for host adaptation. The presence of 549Y in wildlife strains from Serbia, Italy, and South Africa strongly supports the hypothesis that this residue is under positive selection in wildlife hosts and may be a critical determinant of cross-species transmission potential [12, 28]. Furthermore, the Arctic lineage strains from Serbian jackals also exhibited a mutation at position 310, which may affect protein function and virus-host interactions, although the functional significance of this substitution requires further investigation [28].

South American Lineages: A Hotspot of Diversity and Spillover

South America has emerged as a major hotspot of CDV phylogenetic diversity, with multiple lineages co-circulating in both domestic and wild carnivores, as well as in non-carnivore species such as non-human primates. The South America-1 (Europe/South America-1) lineage is widely distributed, but the continent also harbors the South America-2, -3, and -4 lineages, each with distinct geographic and host associations [20, 21, 29]. The South America-4 lineage, for example, has been identified concurrently in domestic dogs and crab-eating foxes (Cerdocyon thous) in Colombia, confirming simultaneous circulation at the wild-domestic interface [21]. Phylogenetic analysis revealed high genetic variability and multiple virus reintroductions, with Colombian strains showing close relationships to CDV strains previously detected in the United States, suggesting transcontinental viral exchange [21]. In Chile, the North/South America-4 lineage was detected for the first time in 2022–2023, co-circulating with the Europe/South America-1 lineage, and Chilean strains shared a close common ancestor with Brazilian and Peruvian viruses, indicating regional viral spread [29].

Perhaps the most alarming development in South America is the repeated spillover of CDV into neotropical primates. In Brazil, CDV was detected in a free-ranging black-tufted marmoset (Callithrix penicillata) during a lethal outbreak in urban parks in Belo Horizonte, with phylogenetic analysis placing the strain close to South American sequences and Vero cell-adapted lineages [20]. Even more striking, a natural coinfection of CDV and yellow fever virus was documented in a neotropical primate of the genus Callithrix in northeastern Brazil, with the CDV sequences forming a divergent lineage closely related to the EU1/South America-1 and South America-2 genotypes [16]. This represents the first report of such a coinfection and raises profound questions about the synergistic effects of multiple viral infections in already threatened primate populations. The ability of CDV to infect and cause fatal disease in non-human primates, which are phylogenetically distant from traditional carnivore hosts, underscores the remarkable plasticity of the CDV H protein and its capacity to utilize alternative receptors or binding conformations [16, 20].

North American Lineages and the Role of Raccoons as Viral Reservoirs

In North America, the phylogenetic landscape of CDV in wildlife is dominated by the America-3 (Edomex), America-4, and America-5 lineages, but recent studies have revealed an even greater diversity than previously appreciated [43, 46]. Anis et al. [43] characterized the H gene of 25 CDV strains from free-ranging wildlife in the United States, including fishers, foxes, skunks, raccoons, wolves, and mink, and identified at least two additional lineages beyond the three major ones. One of these novel lineages grouped with a single isolate from a raccoon in Rhode Island from 2012, while another was entirely independent and genetically distinct from all other strains included in the analysis [43]. The detection of these novel lineages primarily in raccoons suggests that this species may serve as a key reservoir for generating and maintaining genetic variability in CDV populations, acting as a “mixing vessel” for viral evolution [43, 46].

In Canada, a comprehensive phylogenetic study of CDV from ten wild and domestic species in Ontario revealed the existence of seven distinct lineages, including a previously undescribed lineage designated Canada-1 [46]. The Canada-1 lineage was most genetically similar to America-1 sequences but was sufficiently divergent to be considered a distinct lineage. The study also confirmed the presence of multiple co-circulating lineages in Ontario wildlife, with raccoons again playing a central role in the maintenance and transmission of these heterogeneous lineages [46]. Importantly, the study documented the importation of a South American lineage into Ontario via a domestic dog, highlighting the role of animal movement and trade in introducing novel CDV lineages into naive wildlife populations [46]. The genetic heterogeneity observed in North American wildlife raises concerns about potential vaccine escape, as the America-4 lineage has already been shown to have significant antigenic differences from the vaccine strain (America-1) based on virus neutralization assays [32].

Molecular Determinants of Host Adaptation and Lineage Divergence

The phylogenetic diversity of CDV is not merely a matter of geographic clustering; it is underpinned by specific molecular changes in the H protein that govern host range and virulence. The H protein is a 607-amino-acid type II transmembrane glycoprotein that forms homodimers on the viral envelope and is responsible for receptor attachment. The two primary receptors for wild-type CDV are SLAM (CD150), expressed on activated immune cells, and nectin-4 (PVRL4), expressed on epithelial cells [35, 45]. The SLAM-binding region, located in the C-terminal globular head domain of the H protein, is a hotspot for amino acid substitutions that can alter receptor binding affinity and specificity [12, 28].

One of the most well-characterized adaptive mutations is at position 549 of the H protein. As noted earlier, the substitution of histidine (H) with tyrosine (Y) at this position is strongly associated with wildlife hosts and is thought to enhance binding to SLAM receptors of non-canine species [12, 28, 39]. In a study of CDV strains from South African wildlife, all non-canid strains (including lions, leopards, and cheetahs) possessed the 519I/549H combination, while canid strains showed variation at these sites [12]. Similarly, in the Malayan tiger (Panthera tigris jacksoni) from Malaysia, the CDV strain (Asia-1 lineage) harbored both 549H and 519I mutations, indicating adaptation to a non-canid felid host [9]. The 519I mutation, involving an isoleucine at position 519, is also frequently observed in wildlife-adapted strains and may act synergistically with the 549H/Y substitution to modulate receptor binding [9, 12].

Another critical residue is position 530, which lies within the SLAM-binding region. In most CDV strains, position 530 is occupied by asparagine (N), and this conservation is maintained regardless of host species [12]. However, in the Danish mink outbreak of 2012, the majority of viruses from both mink and wildlife contained glycine (G) at position 530, with only three mink viruses showing the Y549H substitution [39]. This suggests that while some residues are highly conserved, others may be subject to lineage- or outbreak-specific selection pressures. The codon usage pattern of the H gene also plays a role in host adaptation. In a study of the Asia-4 lineage from civets in Thailand, the codon usage pattern was found to be more closely related to the codon usage of civets than of dogs, suggesting that the virus had undergone adaptive evolution to optimize translational efficiency in the civet host [47]. This type of codon usage bias may be a general mechanism by which CDV adapts to novel hosts, and it represents an underexplored dimension of phylogenetic diversity.

Emerging Lineages and the Threat to Endangered Species

The discovery of novel CDV lineages in wildlife is often associated with outbreaks in endangered or vulnerable species, underscoring the conservation implications of phylogenetic diversity. The Asia-5 lineage, for example, has been identified in leopards (Panthera pardus) in Nepal, where it caused fatal neurologic disease [13]. Phylogenetic analysis linked these leopard strains to Asia-5 strains circulating in dogs and wild carnivores in Nepal and neighboring India, suggesting that the leopards acquired the virus through predation on infected dogs or other wildlife [13]. Similarly, the Asia-1 lineage was responsible for the first documented CDV infection in a Malayan tiger in Malaysia, and the same lineage has been detected in Javan leopards (Panthera pardus ssp. melas) in Indonesia, indicating a widespread threat to Asian felids [9, 41].

In the United States, the America-4 lineage has been implicated in fatal outbreaks in captive sloths and wolves, as well as in free-ranging fishers and gray foxes [37, 48, 55]. The detection of a distinct New England clade of CDV in eight mesocarnivores (fishers, gray foxes, mink, skunk, and raccoon) from Vermont and New Hampshire in 2016–2017, with no other CDV clade identified in the region during that period, suggests that this clade may be uniquely adapted to the wildlife community of that region [37]. This clade was also found in a subsequent case of concurrent infection with skunk adenovirus-1 and Listeria monocytogenes in a gray fox, highlighting the complex co-infection dynamics that can occur in wildlife populations [33].

The Southern African lineage, as characterized by Loots et al. [12], encompasses strains from four different wildlife species in South Africa, including lions, leopards, cheetahs, and wild dogs. Phylogenetic analysis revealed two possible co-circulating sub-genotypes corresponding to the northern and southern regions of South Africa, and the wildlife strains showed a high degree of similarity to CDV in South African domestic dogs, indicating ongoing spillover from the domestic reservoir [12]. The presence of the 519I/549H combination in all non-canid strains from South Africa further supports the role of these mutations in facilitating cross-species transmission to large felids and other endangered carnivores [12].

Phylogeographic Patterns and the Role of Landscape Connectivity

The spatial distribution of CDV lineages is not random but is shaped by landscape features, host movement patterns, and anthropogenic factors. In the southeastern United States, a study of H-gene sequence diversity in mesocarnivores (raccoons, red foxes, gray foxes, and striped skunks) revealed a clear phylogeographic break at the Mississippi River, with strains east and west of the river forming distinct genetic clusters [19]. Only two eastern samples clustered with western groups, suggesting that the Mississippi River acts as a significant barrier to viral gene flow, likely due to its role in limiting host dispersal [19]. This geographic structure has important implications for disease surveillance and control, as it implies that CDV management strategies may need to be tailored to specific regions.

In Europe, the phylogeographic patterns of the European Wildlife lineage in the Alpine region have been linked to altitude gradients and landscape fragmentation. Carella et al. [2] demonstrated that CDV trends in the Aosta Valley of Italy were strongly related to NDVI entropy changes, which serve as a proxy for landscape fragmentation. Fragmented landscapes can alter host density, movement, and contact rates, thereby influencing viral transmission and evolution [2, 19]. The spatial clustering of CDV cases in areas of medium to high human population density, as observed in the southeastern United States, further underscores the role of anthropogenic land use in shaping viral phylogenies [14, 19]. These findings align with the WOAH and FAO recommendations for integrated surveillance that incorporates ecological and spatial data

Ecological Drivers and Remote-Sensing Models for Canine Distemper Virus Outbreaks

The emergence and propagation of canine distemper virus (CDV) within wildlife populations are governed by a complex interplay of ecological, anthropogenic, and climatic factors that operate across multiple spatial and temporal scales. Understanding these drivers is not merely an academic exercise; it is fundamental to predicting outbreak risk, designing surveillance strategies, and implementing effective management interventions. The integration of remote-sensing technologies with epidemiological modeling has opened a new frontier in wildlife disease ecology, offering the capacity to monitor landscape-level changes that drive pathogen transmission dynamics. This section provides a comprehensive examination of the ecological determinants of CDV outbreaks and the evolving suite of remote-sensing and geospatial analytical tools being developed to model and anticipate these events.

Landscape Fragmentation, Land Use Change, and Habitat Configuration

The alteration of natural landscapes through anthropogenic activity represents a primary ecological driver of CDV dynamics in wildlife. The expansion of human settlements, agricultural intensification, and infrastructure development profoundly reshape habitat configurations, influencing host density, movement patterns, and contact rates at the wildlife-domestic-human interface. Carella et al. [2] provided seminal evidence linking landscape fragmentation, quantified through the entropy of the Normalized Difference Vegetation Index (NDVI), to CDV outbreak waves in the alpine ecosystems of northwestern Italy. Their work demonstrated that anomalies in NDVI entropy, a metric reflecting the heterogeneity and patchiness of vegetation cover, were strongly correlated with CDV prevalence in red foxes (Vulpes vulpes), wolves (Canis lupus), badgers (Meles meles), and beech martens (Martes foina) over a five-year period (2015–2020). The logic underpinning this relationship is ecologically sound: highly fragmented landscapes, characterized by increased edge habitat and interspersion of natural and anthropogenic elements, facilitate greater contact between synanthropic mesocarnivores, domestic dogs, and susceptible wildlife. These ecotones serve as conduits for viral spillover and amplification.

Wilson et al. [19] advanced this understanding in a comprehensive study across the southeastern United States, where they developed generalized linear models to identify environmental predictors of CDV infection in mesocarnivores, including raccoons (Procyon lotor), gray foxes (Urocyon cinereoargenteus), red foxes, and striped skunks (Mephitis mephitis). Their analysis revealed that surface imperviousness, a direct proxy for urbanization, was a significant positive predictor of CDV infection likelihood. Importantly, they identified a nonlinear relationship with human population density: Taylor et al. [14] had previously shown that CDV cases in Georgia were spatially clustered in areas of medium to high human population density, with fewer cases occurring in both the most densely urbanized and the most remote, sparsely populated areas. This pattern suggests a "sweet spot" of anthropogenic disturbance where resource subsidies (e.g., garbage, pet food) support elevated mesocarnivore densities, yet habitat fragmentation remains sufficient to promote inter-individual and inter-species contact. The mechanism is further supported by data from Ontario, Canada, where Giacinti et al. [38] demonstrated that the winter breeding season, characterized by high intraspecific contact and an influx of susceptible juveniles, represents a period of elevated CDV transmission risk in raccoons, a pattern amplified in suburban landscapes.

Anthropogenic Interfaces and the Role of Domestic Dog Populations

The role of domestic dogs (Canis familiaris) as a primary reservoir and bridge host for CDV spillover into wildlife has been a central tenet of CDV epidemiology, yet the evidence reveals a more nuanced and context-dependent relationship. The World Organisation for Animal Health (WOAH) recognizes CDV as a multi-host pathogen with significant implications for both domestic animal health and wildlife conservation, emphasizing the need for integrated surveillance at the domestic-wildlife interface. Angwenyi et al. [6], in their systematic review of CDV in African wildlife from 1978 to 2021, found that while 61% of studies concluded that domestic dogs acted as reservoirs or sources of infection for wildlife, definitive proof of transmission direction was frequently lacking. They highlighted that disease dynamics varied markedly across ecoregions due to differences in land use, dog population density, vaccination coverage, and the ecology of sympatric wildlife. In the Janos Biosphere Reserve, Mexico, Almuna et al. [68] demonstrated that 62% of domestic dogs were seropositive for CDV, with free-roaming owned dogs significantly more likely to be seropositive than those with restricted movement. Direct interactions between these dogs and wild carnivores, including bobcats (Lynx rufus), striped skunks, and gray foxes, were reported, and critically, vaccination rates were abysmally low (7%). This scenario, replicated globally from the Galapagos Islands [18, 40] to the buffer zones of Chitwan National Park in Nepal [60] and protected areas in Cambodia [69], establishes a persistent conduit for viral maintenance and spillover.

However, the paradigm of the domestic dog as the sole or primary reservoir is increasingly recognized as an oversimplification. In many ecosystems, particularly where dog vaccination is partially effective or where feral dog populations are controlled, wildlife themselves can sustain CDV circulation independently. Bianco et al. [15] provided compelling phylogeographic evidence from the Italian Alps, demonstrating that two distinct epidemic waves of CDV (2006–2009 and 2011–2018) in wild carnivores were characterized by different viral variants and diffusion rates, suggesting that the infection was being maintained and spread predominantly within the wildlife host community itself. Similarly, in the southeastern United States, the emergence of the America-4 and America-5 lineages has been linked to stable wildlife reservoirs, particularly raccoons and gray foxes, that have allowed these strains to circulate independently of domestic dog populations [32, 43]. Riley and Wilkes [32] noted that this novel strain first appeared in 2011 and was detected in fully vaccinated adult dogs, raising concerns about potential vaccine escape and underscoring the role of wildlife as a source of novel, antigenically distinct variants.

Climate, Seasonality, and Elevation Gradients

Climatic variables exert profound influences on CDV transmission dynamics, primarily through their effects on host behavior, survival, and viral persistence in the environment. Wilson et al. [19] identified precipitation as a significant positive predictor of CDV infection likelihood in their southeastern US study, a finding that may relate to increased aggregation of hosts around water sources or enhanced environmental stability of the virus under humid conditions. Conversely, elevation was consistently associated with lower CDV risk, a pattern observed in both the alpine regions of Italy [2] and the southern Appalachians of the United States [19]. This elevation gradient likely reflects a combination of factors, including lower host densities at higher altitudes, reduced anthropogenic disturbance, and potentially less favorable conditions for viral transmission.

Seasonality is a critical, yet often underappreciated, driver of CDV outbreaks. Taylor et al. [14] demonstrated that CDV cases in raccoons and gray foxes in Georgia were more likely to occur during the breeding season, a period characterized by increased social contact, territorial defense, and the recruitment of immunologically naïve juveniles into the population. Giacinti et al. [38] provided further mechanistic insight from their longitudinal serologic study of raccoons in Ontario, showing that juveniles were more likely to be seronegative during the late summer and fall (August–November), implying a waning of maternal antibodies and the creation of a large cohort of susceptible individuals. The subsequent winter breeding season then provides the ecological conditions, high contact rates, nutritional stress, and commingling of susceptible and potentially infectious individuals, necessary for an outbreak. This pattern is remarkably consistent across temperate ecosystems, from the Czech Republic [24] to Croatia [34] and Canada [31]. The Food and Agriculture Organization of the United Nations (FAO) has recognized the importance of understanding such seasonal dynamics for designing targeted vaccination and surveillance campaigns in livestock and wildlife interface zones.

Host Community Structure and the Role of Reservoir Species

The composition and density of the multi-host community are fundamental determinants of CDV maintenance and outbreak intensity. CDV is a generalist pathogen capable of infecting over 100 species across multiple mammalian orders, but not all hosts contribute equally to transmission. Raccoons, in particular, have emerged as a keystone reservoir species in North America, a finding robustly supported by multiple lines of evidence. Giacinti et al. [46] demonstrated that raccoons in Ontario harbored at least seven distinct CDV lineages, including a novel Canada-1 lineage, and that their role in maintaining and transmitting these heterogeneous lineages was pivotal. Anis et al. [43] similarly concluded that raccoons may be the host responsible for the genetic variability of newly detected CDV strains in the domestic dog population in the United States. The reservoir competence of raccoons is attributable to their high population densities, particularly in suburban environments, their synanthropic behavior, and their relatively high rates of population turnover, which ensures a continuous supply of susceptible individuals.

In Europe, the red fox often serves as the primary amplification host, with seroprevalence rates ranging from 25% to 60% depending on the region and outbreak phase [2, 24, 34, 59]. However, the system is not static. Blasio et al. [49] demonstrated that in the Alpine ecosystems of northwest Italy, a self-maintained multi-host pathogen system had developed, wherein interspecies transmission from red foxes to other non-canid species, including badgers, martens, and wolves, enhanced pathogen maintenance. This finding is critical because it indicates that even if fox populations were controlled or vaccinated, the presence of alternative hosts could sustain viral circulation. The recent detection of CDV in small mammals, such as tree shrews (Tupaia glis) in Malaysia [23] and neotropical primates (Callithrix spp.) in Brazil [16, 20], further expands our understanding of the CDV host range and challenges the notion that CDV is primarily a disease of carnivores. These novel hosts may serve as unexpected reservoirs or spillover endpoints, with significant implications for conservation of endangered species.

Remote-Sensing Models: From Correlates to Predictive Tools

The application of remote sensing to CDV ecology has evolved from simple correlative studies to sophisticated, spatially explicit modeling frameworks. The foundational work by Carella et al. [2] established NDVI entropy as a powerful proxy for landscape fragmentation and a predictor of CDV outbreak intensity in alpine wildlife. Their model, developed using Earth Observation Data from the Aosta Valley region, demonstrated that changes in the spatial heterogeneity of vegetation, captured through the entropy metric, were strongly correlated with the temporal dynamics of CDV prevalence across multiple host species. This approach is biologically meaningful because NDVI entropy integrates the effects of both natural and anthropogenic disturbances on habitat configuration, providing a single metric that reflects the degree of landscape dissection and the potential for host contact.

More recent work has advanced toward quantitative risk mapping and transmission modeling. Lazarus et al. [67] developed a spatial heat map and basic reproduction number (R0) model for CDV in wildlife populations, integrating field observations, environmental data (including land cover and climate variables), and reported CDV cases to predict areas of higher transmission risk. Their model explicitly incorporated environmental factors, animal density, and the degree of human-wildlife interface, providing a preliminary tool for identifying high-risk zones and supporting targeted monitoring. This represents a critical step forward, moving from retrospective correlation to prospective risk assessment. The approach aligns with the WOAH's Terrestrial Animal Health Code recommendations for surveillance of emerging diseases, emphasizing the use of risk-based strategies to optimize resource allocation.

Spatial clustering analyses have further refined our understanding of CDV distribution. Wilson et al. [19] applied Ripley's K function to CDV-positive mesocarnivore cases and found significant spatial clustering at larger distances, indicating that outbreaks are not randomly distributed but rather aggregate in specific landscape contexts. Giacinti et al. [31] compared passive and enhanced-passive surveillance components for raccoon CDV in Ontario and demonstrated that the combination of both approaches provided a more representative geographic picture than either alone, but also highlighted the biases inherent in each method. These methodological insights are crucial for interpreting surveillance data and for designing future monitoring programs.

Temporal Dynamics and Phylogeographic Modeling

Understanding the temporal dynamics of CDV requires integrating ecological drivers with viral evolution and spread. Bianco et al. [15] applied extensive phylogeographic analysis to CDV strains from the Italian Alps, revealing that two distinct epidemic waves (2006–2009 and 2011–2018) were caused by separate viral introductions with markedly different diffusion rates and spatial distributions. This finding suggests that the ecological and demographic context of the host population, not just viral genetics, determines outbreak dynamics. The first wave spread more rapidly and extensively, possibly facilitated by higher host densities or greater landscape connectivity at that time, while the second wave was more spatially restricted. This temporal heterogeneity underscores the need for dynamic, rather than static, predictive models.

Time-series models have also been employed to forecast CDV cases. Taylor et al. [14] developed autoregressive integrated moving average (ARIMA) models using 45 years of passive surveillance data from the southeastern United States. Their best-performing model for gray foxes incorporated CDV case numbers from the previous two months and raccoon cases in the present month, while the raccoon model used cases from the previous month and gray fox cases from the present and previous two months. These cross-species interactions highlight the interconnectedness of the multi-host community and the potential for one species to serve as a sentinel for another. The models also confirmed the temporal clustering of cases during breeding seasons, providing a statistical framework for predicting periods of elevated risk.

The integration of remote-sensing-derived environmental layers with phylogeographic and time-series analyses represents the frontier of CDV modeling. As the Centers for Disease Control and Prevention (CDC) has emphasized for other emerging infectious diseases, the ability to predict where and when outbreaks are likely to occur is essential for proactive, rather than reactive, public health and conservation interventions. For CDV, this means moving beyond simple presence-absence maps to dynamic, risk-based models that incorporate real-time or near-real-time satellite data on vegetation phenology, urbanization, and climate. The work of Carella et al. [2] provides a template for such an approach, demonstrating that NDVI entropy, a metric accessible from freely available satellite imagery, can serve as a robust predictor of CDV dynamics. Future models should aim to integrate multiple remote-sensing proxies (e.g., land surface temperature, precipitation, impervious surface cover) with host demographic data and viral genetic information to create truly predictive frameworks. Such models would not only advance our fundamental understanding of CDV ecology but also provide actionable intelligence for wildlife managers and conservation practitioners seeking to mitigate the impact of this devastating pathogen on vulnerable populations.

One Health Implications and Management Strategies for Canine Distemper Virus in Wildlife

The emergence and re-emergence of canine distemper virus (CDV) in wildlife populations worldwide represent a paradigmatic challenge for the One Health framework, which explicitly recognizes the inextricable linkages among human health, domestic animal health, wildlife health, and ecosystem integrity. Unlike pathogens with direct zoonotic potential, CDV does not cause disease in humans; however, the virus is closely related to the human measles morbillivirus and the now-eradicated rinderpest virus of cattle, sharing a common evolutionary history and fundamental mechanisms of immune modulation and pathogenesis [3, 26]. The World Organisation for Animal Health (WOAH) classifies CDV as a highly contagious pathogen with significant implications for terrestrial animal health, biodiversity conservation, and the stability of ecological communities. The multifaceted nature of CDV epidemiology demands that we move beyond species-centric management and embrace integrated strategies that address the virus at the domestic–wildlife–environment interface, incorporating insights from landscape ecology, molecular virology, wildlife conservation medicine, and public health policy.

Implications for Biodiversity and Ecosystem Health at the Human–Animal Interface

The most profound One Health implication of CDV circulation in wildlife is the direct threat it poses to biodiversity, particularly to endangered and keystone species. CDV has been documented in over 20 families of mammals, spanning at least six orders, including Canidae, Felidae, Mustelidae, Procyonidae, Ursidae, Viverridae, Hyaenidae, and even non-carnivorous orders such as primates and artiodactyls [45]. This extraordinary host range is facilitated by the virus’s ability to utilize the signaling lymphocytic activation molecule (SLAM) receptor, which is conserved across mammalian species, and nectin-4 for epithelial entry [45]. Consequently, outbreaks have caused catastrophic mortality in populations of African wild dogs, Ethiopian wolves, Amur tigers, lions, and numerous other threatened carnivores [6, 17]. In Africa, a systematic review of CDV in wildlife from 1978–2021 documented mortality rates between 30% and 94% across affected species, with 64% (7 of 11) of susceptible species classified as threatened by the International Union for Conservation of Nature (IUCN) [6]. These population-level impacts are not merely conservation concerns; they represent a disruption of ecological functions, including predation, competition, and scavenging services, with cascading effects on ecosystem health.

The situation in the Galapagos Islands exemplifies the convergence of conservation and One Health crises. Domestic dogs on the archipelago serve as a reservoir for CDV, and serological surveys of Galapagos sea lions (Zalophus wollebaeki) have confirmed continuous and increasing circulation of the virus, with neutralizing antibody prevalence rising from 19.6% in 2016 to 53.1% in 2017 [18]. Despite dog population control and vaccination policies, a major CDV outbreak in dogs occurred in 2019, with a positivity rate of 74.4%, underscoring the persistent threat to the endemic and endangered sea lion population [40]. Similarly, the detection of CDV in neotropical primates, such as black-tufted marmosets (Callithrix penicillata) in Brazil, which presented with neurological signs and pantropic viral distribution, signals a worrying expansion of the host range into new taxonomic orders previously considered at low risk [20]. Furthermore, a natural coinfection of CDV and yellow fever virus was documented in a free-ranging Callithrix primate, highlighting the potential for complex disease interactions that complicate diagnosis and management [16]. These events underscore that CDV is no longer a disease of domestic dogs; it is a multi-host pathogen of global conservation significance, and its emergence in novel hosts demands intensified surveillance and cross-disciplinary collaboration.

The domestic dog–wildlife interface remains the critical nexus for spillover events. Free-roaming and owned but unrestrained dogs in rural and peri-urban areas bordering protected habitats consistently demonstrate high seroprevalence to CDV, ranging from 40% in Cambodia to 80% in Nepal’s Chitwan National Park buffer zone and as high as 70% in the Annapurna Conservation Area [60, 69, 71, 74]. This proximity is not incidental; it is a direct consequence of anthropogenic landscape change, human population expansion, and the encroachment of settlements into wildlife habitat [2]. A systematic review of 23 reports investigating the role of domestic dogs as CDV reservoirs for African wildlife found that 61% concluded that dogs acted as reservoirs or sources of infection, although the review also cautioned that the role of wildlife-to-wildlife transmission and the possibility of a “meta-reservoir” system involving multiple species should not be underestimated [6]. Indeed, the concept of a single reservoir species is increasingly untenable. As Wilkes (2022) articulates, CDV appears to be maintained by a “metareservoir” rather than a single species, requiring a paradigm shift in vaccination strategy: vaccinating only domestic dogs at the wildlife interface has demonstrably failed to control virus spread, necessitating consideration of direct vaccination of threatened wildlife species themselves [17]. This viewpoint is supported by phylogenetic evidence from the Americas, Europe, and Asia, where distinct CDV lineages circulate in wildlife populations with minimal or no apparent connection to domestic dogs, suggesting self-sustaining cycles within wild carnivore communities [15, 32, 37, 43, 46].

Integrated Surveillance and Diagnostic Strategies

Effective management of CDV in wildlife is fundamentally dependent upon robust, integrated surveillance systems that can detect incursions early, track viral evolution, and inform targeted interventions. Traditional passive surveillance, which relies on the submission of sick or dead animals, has inherent biases, often underrepresenting the true prevalence and spatial distribution of infection [31]. Studies comparing passive and enhanced-passive surveillance in raccoons in Ontario, Canada, revealed that the two components generated different estimates of positivity, geographic distribution, and host–environment associations, highlighting the need for methodological standardization and the integration of multiple data streams [31]. Temporal patterns also emerge from long-term passive surveillance datasets; analysis of 45 years of CDV cases (1975–2019) from the Southeastern Cooperative Wildlife Disease Study in the United States demonstrated that cases in gray foxes and raccoons were more likely to occur during breeding seasons and were spatially clustered in areas of medium to high human population density, corresponding to suburban habitats where mesocarnivore densities are highest [14].

The molecular toolkit for CDV surveillance has advanced considerably. The development of a validated, pan-genotypic real-time quantitative reverse transcription-PCR (RT-qPCR) assay targeting a conserved region of the phosphoprotein (P) gene represents a significant step forward, enabling detection of all known CDV genotypes, including those from novel lineages for which full genome sequences are unavailable [8]. This is particularly crucial in geographic regions where multiple lineages co-circulate, such as the southeastern United States, where at least five distinct lineages (America-2, America-3/Edomex, America-4, America-5, and a distinct New England wildlife clade) have been identified in wildlife [32, 37, 43]. Portable, point-of-care qPCR platforms, such as the Biomeme two3™, have been validated for CDV detection and offer the potential for real-time diagnosis in remote and resource-limited settings, empowering wildlife biologists and veterinarians to make immediate management decisions without the delays of sample transport to centralized laboratories [54]. However, careful validation is essential, as decreased diagnostic sensitivity relative to laboratory-based methods has been observed with field-deployable platforms [54].

Complementary serological surveillance provides critical insights into past exposure, population immunity, and transmission dynamics. The use of protein A/G conjugates in enzyme-linked immunosorbent assays (ELISAs) has expanded the ability to screen multiple mammalian species, including raccoons, raccoon dogs, and sloths, where species-specific secondary antibodies are unavailable [48, 61]. For example, infection of Linnaeus’s 2-toed sloths with the American-4 strain led to fatal disease without typical central nervous system lesions, yet viral antigen was detected in vessel walls and multiple organs, emphasizing the need for comprehensive histopathological and immunohistochemical evaluation combined with molecular confirmation [48]. Longitudinal serological studies in free-ranging raccoons in Ontario have further revealed that CDV exposure may induce immune amnesia, analogous to the effect described for measles virus in humans, where infection leads to a decrease in antibody titers to other previously encountered pathogens, such as canine parvovirus [38]. This finding has profound implications for population immunity and the interpretation of serosurveillance data, suggesting that CDV infection may compromise herd immunity to other pathogens, potentially exacerbating rabies control efforts and other disease management programs [38].

Vaccination Strategies at the Wildlife–Domestic Interface

The management of CDV in wildlife is inextricably tied to vaccination, yet this strategy remains one of the most contentious and logistically challenging aspects of One Health intervention. Historically, the modified-live virus (MLV) vaccines developed for domestic dogs have been used off-label in a wide range of nondomestic species, with variable safety and efficacy profiles. The use of MLV vaccines in endangered wildlife carries the risk of vaccine-induced disease, particularly in immunocompromised or highly susceptible species, and there are insufficient safety data for most nondomestic taxa [17, 50]. Consequently, the recombinant canarypox-vectored CDV vaccine (RECOMBITEK®) has emerged as a safer alternative for certain wildlife species, including black-footed ferrets, pandas, and some felids. In a controlled study of wild-caught raccoons, two serial doses of the canarypox-vectored vaccine administered subcutaneously induced a virus-neutralizing antibody response (titer ≥ 1:24) in 67% of initially seronegative animals after a booster, suggesting immunogenicity in this species, although the presence of pre-existing maternal antibodies interfered with the response [65].

Despite these advances, the logistical barriers to vaccinating free-ranging wildlife populations are formidable. Trap-vaccinate-release (TVR) programs are labor-intensive, expensive, and cannot achieve the population-level coverage required to interrupt transmission, especially for species with large home ranges or high population densities. Oral vaccination, which has been successfully deployed for rabies control in foxes and raccoons in Europe and North America, represents a promising avenue for CDV. Studies in mice have demonstrated the feasibility of replication-competent adenovirus-vectored oral vaccines encoding the CDV hemagglutinin (H) protein, which induced detectable and neutralizing serum antibody responses [72]. Similarly, DNA vaccines encapsulated in lipid nanoparticles encoding the fusion (F) and H proteins of a field CDV strain have shown safety and immunogenicity in dogs, foxes, and raccoon dogs, with long-lasting neutralizing antibody responses exceeding 300 days in dogs [73]. These platforms offer the potential for large-scale oral bait distribution, analogous to rabies vaccination campaigns, and could be integrated into existing wildlife management infrastructure.

Nonetheless, significant challenges remain. The genetic diversity of CDV, with at least 18 recognized lineages based on the H gene, poses a risk of vaccine escape if vaccines are based on strains that are antigenically divergent from circulating wild-type viruses [42, 50]. The emergence of novel lineages in the United States, such as the America-4 strain associated with vaccine failure in fully vaccinated domestic dogs, underscores this concern [32]. Phylogenetic analyses have demonstrated amino acid substitutions at key receptor binding sites, including the Y549H mutation in the H protein, which is frequently associated with adaptation to non-canid hosts and increased virulence [4, 9, 12, 28]. The Asia-6 lineage, identified in red pandas in China, shows a deep genetic distance from all recognized lineages, diverging from Asia-4 since 1884, and its antigenic relationship to vaccine strains is unknown [42]. Therefore, a One Health vaccination strategy must incorporate ongoing genomic surveillance to monitor antigenic drift and ensure that vaccine antigens remain relevant to circulating strains. The development of a universal peptide-based vaccine candidate, designed from consensus sequences of the H and F proteins and evaluated in silico and in vitro for safety, represents a promising approach that could circumvent the limitations of lineage-specific vaccines [27].

Biosecurity, Risk Mitigation, and Landscape-Level Management

For captive wildlife populations, including those in zoos, rescue centers, and conservation breeding programs, stringent biosecurity measures are essential to prevent CDV introduction. A quantitative risk assessment for captive tigers at wildlife stations in Thailand identified that the absence of intervention measures resulted in a high risk of CDV introduction (probability of entry = 0.858), with the most influential pathways being contaminated human hands, infected wild animals, and contaminated equipment [7]. The implementation of a comprehensive suite of interventions, including quarantine and isolation of infected animals, screening tests for healthy individuals, CDV vaccination campaigns, hand hygiene protocols for staff and visitors, restriction of dog and cat access to tiger enclosures, disinfection of transport vehicles, and dedicated equipment for each cage, reduced the median risk of introduction to 0.089, representing an 89.6% risk reduction [7]. These findings have direct applicability to any captive facility housing CDV-susceptible species and should be codified as standard operating procedures.

In free-ranging populations, landscape-level interventions informed by spatial epidemiology offer additional leverage points. The use of satellite-derived remote sensing data, such as the normalized difference vegetation index (NDVI) entropy, has been tentatively modeled to predict CDV outbreaks in Alpine wildlife in Italy, as NDVI entropy reflects landscape fragmentation and ecological connectivity that influence wildlife movement and contact rates [2]. This approach identified that CDV trends were strongly related to altitude gradients and NDVI entropy changes, suggesting that landscape disturbances due to anthropogenic or natural causes can be monitored from space to predict periods of heightened transmission risk [2]. Similarly, in the southeastern United States, a generalized linear model revealed that surface imperviousness (a proxy for urbanization), precipitation, and subadult/adult age classes were significant positive predictors of CDV infection in mesocarnivores, while elevation had a negative association [19]. These spatial models can be used to prioritize surveillance efforts in high-risk zones, enabling earlier outbreak detection and more efficient allocation of limited resources. Heat mapping and estimation of the basic reproduction number (R₀) from field observations, environmental data, and reported CDV cases can further delineate transmission risk areas, guiding targeted monitoring and evidence-based conservation decisions [67].

The Role of Domestic Dog Management in Mitigating Spillover

Domestic dogs remain the most tractable management target for reducing CDV spillover into wildlife, yet achieving adequate vaccination coverage in free-roaming dog populations in low- and middle-income countries remains an enormous challenge. Seroprevalence surveys in rural communities bordering protected areas consistently reveal low vaccination rates and high exposure: only 7% of domestic dogs in the Janos Biosphere Reserve in Mexico were vaccinated, while 62% were seropositive to CDV [68]. In Romania, a seroprevalence of 10.8% was found in urban dogs, with dogs in good body condition more likely to be seropositive, potentially reflecting increased roaming behavior and contact with conspecifics [70]. In Bhutan, seroprevalence in dogs bordering the Jigme Khesar Strict Nature Reserve was 11.3%, and dogs sampled in summer were more likely to be seropositive than those sampled in winter, possibly due to seasonal differences in contact rates [71]. These data indicate that CDV is actively circulating within domestic dog populations adjacent to wildlife habitat, maintaining a persistent source of infection.

A meta-analysis of 53 cross-sectional studies encompassing 11,527 dogs globally found that the pooled frequency of CDV positivity based on molecular detection was 33% and based on serology was 46%, with free-ranging dogs (OR = 1.44), dogs over 24 months of age (OR = 1.83), and unvaccinated dogs (OR = 2.92) significantly more likely to be infected [57]. Conversely, dogs with a complete vaccination history had a significantly lower odds of infection (OR = 0.18) [57]. These findings reinforce the centrality of dog vaccination as a cost-effective intervention. However, vaccination alone is insufficient if dog population dynamics are not addressed. In the Annapurna Conservation Area, Nepal, 58% of owned dogs were allowed to roam freely, and many originated from urban areas outside the region, facilitating the introduction and maintenance of CDV [74]. The authors recommended control of dog immigration, combined with vaccination and neutering, to mitigate spillover risk [74]. This integrated approach aligns with the WOAH and FAO guidelines for rabies elimination, which emphasize the importance of responsible dog ownership, population management, and community engagement. A similar strategy applied to CDV would yield dual benefits for domestic animal health and wildlife conservation.

Addressing Emerging Threats: Coinfections, Climate Change, and Novel Hosts

The One Health framework must also account for the complex interactions between CDV and other pathogens, which can exacerbate disease severity and complicate diagnosis. Coinfection of CDV with rabies virus is a particularly concerning scenario, as both diseases can present with indistinguishable neurological signs and are managed through completely different public health protocols. In a study from New York State, concurrent CDV infection was detected in 5.6% of animals submitted for routine rabies testing, with coinfection rates of approximately 9% in raccoons, 2% in red foxes, and 0.4% in striped skunks [51]. This finding underscores the importance of performing confirmatory testing for both pathogens in cases of neurologic disease in wildlife, particularly in regions where rabies is endemic. The detection of CDV in a Malayan tiger (Panthera tigris jacksoni) in Malaysia, with the virus belonging to the Asia-1 lineage and bearing the 549H and 519I mutations associated with adaptation to non-canid hosts, further illustrates the capacity of CDV to jump to novel, vulnerable apex predators [9]. The discovery that small mammals, such as the common tree shrew (Tupaia glis), can harbor CDV RNA and may act as intermediate hosts in transmission networks adds another layer of complexity to the epidemiology, as these species are often overlooked in surveillance programs [23].

Climate change is expected to alter CDV dynamics by shifting the geographic ranges of reservoir hosts and the seasonal patterns of transmission. In Alpine regions, warming temperatures may facilitate the expansion of mesocarnivore populations into higher elevations, while extreme weather events could concentrate animals around limited resources, increasing contact rates [2, 15]. Additionally, environmental contamination may play a role in transmission; CDV was detected in fleas (Ceratophyllus sciurorum) collected during an outbreak in Danish farmed mink, and vertical transmission was documented in a wild ferret, indicating that the virus can persist through routes beyond direct animal-to-animal contact [39]. These findings suggest that a comprehensive management strategy must consider the environmental persistence of the virus and the potential for arthropod vectors to contribute to transmission.

Policy, Legal Frameworks, and the Path Forward

Effective management of CDV in wildlife requires supportive policy and legal frameworks at local, national

References

[1] Alfano F, Lucibelli MG, D'Alessio N, Auriemma C, Rea S, Sgroi G, et al.. Detection of canine distemper virus in wildlife in Italy (2022–2024). Frontiers in Veterinary Science. 2025. DOI: https://doi.org/10.3389/fvets.2025.1527550

[2] Carella E, Orusa T, Viani A, Meloni D, Borgogno-Mondino E, Orusa R. An Integrated, Tentative Remote-Sensing Approach Based on NDVI Entropy to Model Canine Distemper Virus in Wildlife and to Prompt Science-Based Management Policies. Animals. 2022. DOI: https://doi.org/10.3390/ani12081049

[3] Oleaga Á, Vázquez C, Royo L, Barral TD, Bonnaire D, Armenteros JA, et al.. Canine distemper virus in wildlife in southwestern Europe.. Transboundary and Emerging Diseases. 2021. DOI: https://doi.org/10.1111/tbed.14323

[4] Trogu T, Castelli A, Canziani S, Tolini C, Carrera M, Sozzi E, et al.. Detection and Molecular Characterization of Canine Distemper Virus in Wildlife from Northern Italy. Pathogens. 2022. DOI: https://doi.org/10.3390/pathogens11121557

[5] Macías-González J, Granado-Gil R, Mendoza-González L, Pedroza-Roldán C, Alonso-Morales R, Realpe-Quintero M. Canine Distemper Virus in Mexico: A Risk Factor for Wildlife. Viruses. 2025. DOI: https://doi.org/10.3390/v17060813

[6] Angwenyi S, Rooney N, Eisler M. ARE DOMESTIC DOGS (CANIS FAMILIARIS) THE FAMILY SCAPEGOATS? A SYSTEMATIC REVIEW OF CANINE DISTEMPER VIRUS IN AFRICAN WILDLIFE, 1978–2021. Journal of Wildlife Diseases. 2024. DOI: https://doi.org/10.7589/JWD-D-24-00017

[7] Tonchiangsai K, Wiratsudakul A, Kasemsuwan S, Buddhirongawatr R, Thanapongtharm W, Kledmanee K, et al.. Quantitative risk assessment and interventional recommendations for preventing canine distemper virus infection in captive tigers at selected wildlife stations in Thailand. PLoS ONE. 2025. DOI: https://doi.org/10.1371/journal.pone.0320657

[8] Geiselhardt F, Peters M, Jo W, Schadenhofer A, Puff C, Baumgärtner W, et al.. Development and Validation of a Pan-Genotypic Real-Time Quantitative Reverse Transcription-PCR Assay To Detect Canine Distemper Virus and Phocine Distemper Virus in Domestic Animals and Wildlife. Journal of Clinical Microbiology. 2022. DOI: https://doi.org/10.1128/jcm.02505-21

[9] Sadali MFM, Mariatulqabtiah AR, Salleh A, Zahli NI, Azizan TRPT, Ahmad H, et al.. Molecular characterisation and histopathological analysis of canine distemper virus in a Malayan tiger (Panthera tigris jacksoni). Journal of Veterinary Sciences. 2025. DOI: https://doi.org/10.4142/jvs.25092

[10] Jayappa K, Rajkhowa TK, Choudhury FA, Semy PY, Yama T, Khithie J. Canine Distemper Virus in Northeast India: Genetic Diversity and Spillover Potential in the Indo-Burma Biodiversity Hotspot.. The Veterinary Journal. 2025. DOI: https://doi.org/10.1016/j.tvjl.2025.106481

[11] Kimpston CN, Hatke AL, Castelli B, Otto N, Tiffin HS, Machtinger E, et al.. High Prevalence of Antibodies against Canine Parvovirus and Canine Distemper Virus among Coyotes and Foxes from Pennsylvania: Implications for the Intersection of Companion Animals and Wildlife. Microbiology spectrum. 2022. DOI: https://doi.org/10.1128/spectrum.02532-21

[12] Loots AK, Mokgokong PS, Mitchell E, Venter E, Kotzé A, Dalton D. Phylogenetic analysis of canine distemper virus in South African wildlife. PLoS ONE. 2018. DOI: https://doi.org/10.1371/journal.pone.0199993

[13] Sadaula A, Manandhar P, Shrestha BK, Thapa PJ, Nepali S, Joshi JD, et al.. Phylogenetic analysis linked fatal neurologic disease in leopards (Panthera pardus) to Asia-5 lineage of canine distemper virus in Nepal. Virus Research. 2024. DOI: https://doi.org/10.1016/j.virusres.2024.199463

[14] Taylor K, Wilson J, Park AW, Nemeth N, Yabsley M, Fenton H, et al.. TEMPORAL AND SPATIAL PATTERNS IN CANINE DISTEMPER VIRUS CASES IN WILDLIFE DIAGNOSED AT THE SOUTHEASTERN COOPERATIVE WILDLIFE DISEASE STUDY, 1975–2019. Journal of Wildlife Diseases. 2021. DOI: https://doi.org/10.7589/JWD-D-20-00212

[15] Bianco A, Zecchin B, Fusaro A, Schivo A, Ormelli S, Bregoli M, et al.. Two waves of canine distemper virus showing different spatio-temporal dynamics in Alpine wildlife (2006-2018).. Infection, Genetics and Evolution. 2020. DOI: https://doi.org/10.1016/j.meegid.2020.104359

[16] Mares-Guia MA, Furtado MC, Chalhoub FLL, Portugal MD, Coelho JMCdO, Filippis ABDd, et al.. Coinfection with Canine Distemper Virus and Yellow Fever Virus in a Neotropical Primate in Brazil. Viruses. 2024. DOI: https://doi.org/10.2139/ssrn.4819596

[17] Wilkes R. Canine Distemper Virus in Endangered Species: Species Jump, Clinical Variations, and Vaccination. Pathogens. 2022. DOI: https://doi.org/10.3390/pathogens12010057

[18] Ruíz-Sáenz J, Barragán V, Grijalva-Rosero CJ, Díaz EA, Páez-Rosas D. Seroconversion in Galapagos Sea Lions (Zalophus wollebaeki) Confirms the Presence of Canine Distemper Virus in Rookeries of San Cristóbal Island. Animals. 2023. DOI: https://doi.org/10.3390/ani13233657

[19] Wilson J, Rubio S, Salvador LCM, Nemeth NM, Fishburn JD, Gottdenker N. Canine distemper virus phylogenetic structure and ecological correlates of infection in mesocarnivores across anthropogenic land use gradients. Microbiology spectrum. 2025. DOI: https://doi.org/10.1128/spectrum.01225-24

[20] Campos BHd, Santos DDD, Duarte JR, Amaral VHB, Figueiredo C, Vieira AD, et al.. Lethal Canine Distemper Virus (Morbillivirus canis) Outbreak in Free-Ranging Black-Tufted Marmosets (Callithrix penicillata) in Brazil: Clinical, Pathological, Genotypical Evaluation, and Assessment of Viral Tropism. Transboundary and Emerging Diseases. 2025. DOI: https://doi.org/10.1155/tbed/4701926

[21] Rios-Usuga C, Ortiz-Pineda MC, Aguirre-Catolico SD, Quiroz V, Ruíz-Sáenz J. Concurrent Circulation of Canine Distemper Virus (South America-4 Lineage) at the Wild–Domestic Canid Interface in Aburrá Valley, Colombia. Viruses. 2025. DOI: https://doi.org/10.3390/v17050649

[22] Xiao L, Wu Z, Su J, Wu Q. Development of a potent neutralizing nanobody against canine distemper virus hemagglutinin protein. Frontiers in Immunology. 2025. DOI: https://doi.org/10.3389/fimmu.2025.1585793

[23] Lazarus BA, Sadali MFM, Kamal FM, Hua KK, Wahab RA, Kaderi M, et al.. Preliminary study of canine distemper virus transmission from small mammals to Malayan tiger at Kampung Besul Lama, Terengganu, Malaysia. Veterinary World. 2025. DOI: https://doi.org/10.14202/vetworld.2025.791-798

[24] Kličková E, Černíková L, Dumondin A, Bártová E, Budíková M, Sędłak K. Canine Distemper Virus in Wild Carnivore Populations from the Czech Republic (2012–2020): Occurrence, Geographical Distribution, and Phylogenetic Analysis. Life. 2022. DOI: https://doi.org/10.3390/life12020289

[25] Adhikari R, Shrestha M, Puri G, Regmi GR, Ghimire T. Canine Distemper Virus (CDV): an emerging threat to Nepal’s wildlife. . 2020. DOI: https://doi.org/10.3126/asta.v1i1.30294

[26] Rivera-Martínez A, Rodríguez-Alarcón C, Adame-Gallegos J, Laredo-Tiscareño S, Luna-Santillana EDd, Hernández-Triana L, et al.. Canine Distemper Virus: Origins, Mutations, Diagnosis, and Epidemiology in Mexico. Life. 2024. DOI: https://doi.org/10.3390/life14081002

[27] Rendon-Marin S, Ruíz-Sáenz J. Universal peptide-based potential vaccine design against canine distemper virus (CDV) using a vaccinomic approach. Scientific Reports. 2024. DOI: https://doi.org/10.1038/s41598-024-67781-5

[28] Glišić D, Kuručki M, Ćirović D, Šolaja S, Mirčeta J, Milićević V. Molecular analysis of canine distemper virus H gene in the golden jackal (Canis aureus) population from Serbia. BMC Veterinary Research. 2024. DOI: https://doi.org/10.1186/s12917-024-04284-5

[29] Ariyama N, Agüero B, Bennett B, Urzúa C, Berríos F, Verdugo C, et al.. Genetic Characterization of Canine morbillivirus (Canine Distemper Virus) Field Strains in Dogs, Chile, 2022–2023. Transboundary and Emerging Diseases. 2024. DOI: https://doi.org/10.1155/2024/9993255

[30] Munkhtsetseg A, Batmagnai E, Odonchimeg M, Ganbat G, Enkhmandakh Y, Ariunbold G, et al.. Genome sequencing of canine distemper virus isolates from unvaccinated dogs in Mongolia.. The Veterinary Journal. 2024. DOI: https://doi.org/10.1016/j.tvjl.2024.106231

[31] Giacinti J, Pearl D, Ojkić D, Jardine C. COMPARISON OF TWO SURVEILLANCE COMPONENTS FOR INVESTIGATING THE EPIDEMIOLOGY OF CANINE DISTEMPER VIRUS IN RACCOONS (PROCYON LOTOR). Journal of Wildlife Diseases. 2021. DOI: https://doi.org/10.7589/JWD-D-19-00001

[32] Riley M, Wilkes R. Sequencing of emerging canine distemper virus strain reveals new distinct genetic lineage in the United States associated with disease in wildlife and domestic canine populations. Virology Journal. 2015. DOI: https://doi.org/10.1186/s12985-015-0445-7

[33] Needle D, Marr JL, Park CJ, Andam CP, Wise A, Maes R, et al.. Concurrent Infection of Skunk Adenovirus-1, Listeria monocytogenes, and a Regionally Specific Clade of Canine Distemper Virus in One Gray Fox (Urocyon cinereoargenteus) and Concurrent Listeriosis and Canine Distemper in a Second Gray Fox. Pathogens. 2020. DOI: https://doi.org/10.3390/pathogens9070591

[34] Prpić J, Lojkić I, Keros T, Krešić N, Jemeršić L. Canine Distemper Virus Infection in the Free-Living Wild Canines, the Red Fox (Vulpes vulpes) and Jackal (Canis aureus moreoticus), in Croatia. Pathogens. 2023. DOI: https://doi.org/10.3390/pathogens12060833

[35] Gradauskaite V, Inglebert M, Doench JG, Scherer M, Dettwiler M, Wyss M, et al.. LRP6 Is a Functional Receptor for Attenuated Canine Distemper Virus. mBio. 2023. DOI: https://doi.org/10.1128/mbio.03114-22

[36] Chludzinski E, Ciurkiewicz M, Stoff M, Klemens J, Krüger J, Shin D, et al.. Canine Distemper Virus Alters Defense Responses in an Ex Vivo Model of Pulmonary Infection. Viruses. 2023. DOI: https://doi.org/10.3390/v15040834

[37] Needle D, Burnell VC, Forzán M, Dubovi E, Schuler K, Bernier C, et al.. Infection of eight mesocarnivores in New Hampshire and Vermont with a distinct clade of canine distemper virus in 2016–2017. Journal of Veterinary Diagnostic Investigation. 2019. DOI: https://doi.org/10.1177/1040638719847510

[38] Giacinti J, Pearl D, Ojkić D, Bondo K, Jardine C. CANINE DISTEMPER VIRUS ECOLOGY: INSIGHTS FROM A LONGITUDINAL SEROLOGIC STUDY IN WILD RACCOONS (PROCYON LOTOR). Journal of Wildlife Diseases. 2023. DOI: https://doi.org/10.7589/JWD-D-22-00052

[39] Trebbien R, Chriel M, Struve T, Hjulsager C, Larsen G, Larsen L. Wildlife Reservoirs of Canine Distemper Virus Resulted in a Major Outbreak in Danish Farmed Mink (Neovison vison). PLoS ONE. 2014. DOI: https://doi.org/10.1371/journal.pone.0085598

[40] Vega-Mariño P, Olson J, Howitt B, Criollo R, Figueroa L, Orlando S, et al.. A recent distemper virus outbreak in the growing canine populations of Galapagos Islands: a persistent threat for the endangered Galapagos Sea Lion. Frontiers in Veterinary Science. 2023. DOI: https://doi.org/10.3389/fvets.2023.1154625

[41] Rahman DA, Saepuloh U, Santosa Y, Darusman HS, Pinondang IMR, Kindangen AS, et al.. Molecular diagnosis with the corresponding clinical symptoms of canine distemper virus infection in javan leopard (Panthera pardus ssp. melas). Heliyon. 2022. DOI: https://doi.org/10.1016/j.heliyon.2022.e11341

[42] Wang R, Wang X, Zhai J, Zhang P, Irwin D, Shen X, et al.. A new canine distemper virus lineage identified from red pandas in China.. Transboundary and Emerging Diseases. 2021. DOI: https://doi.org/10.1111/tbed.14370

[43] Anis E, Needle D, Stevens B, Yan L, Wilkes R. GENETIC CHARACTERISTICS OF CANINE DISTEMPER VIRUSES CIRCULATING IN WILDLIFE IN THE UNITED STATES. Journal of zoo and wildlife medicine. 2020. DOI: https://doi.org/10.1638/2019-0052

[44] Ricci I, Cersini A, Manna G, Marcario GA, Conti R, Brocherel G, et al.. A Canine Distemper Virus Retrospective Study Conducted from 2011 to 2019 in Central Italy (Latium and Tuscany Regions). Viruses. 2021. DOI: https://doi.org/10.3390/v13020272

[45] Duque-Valencia J, Sarute N, Olarte‐Castillo XA, Ruíz-Sáenz J. Evolution and Interspecies Transmission of Canine Distemper Virus, An Outlook of the Diverse Evolutionary Landscapes of a Multi-Host Virus. Viruses. 2019. DOI: https://doi.org/10.3390/v11070582

[46] Giacinti J, Pearl D, Ojkić D, Campbell GD, Jardine C. Genetic characterization of canine distemper virus from wild and domestic animal submissions to diagnostic facilities in Canada.. Preventive Veterinary Medicine. 2021. DOI: https://doi.org/10.1016/j.prevetmed.2021.105535

[47] Piewbang C, Chansaenroj J, Kongmakee P, Banlunara W, Poovorawan Y, Techangamsuwan S. Genetic Adaptations, Biases, and Evolutionary Analysis of Canine Distemper Virus Asia-4 Lineage in a Fatal Outbreak of Wild-Caught Civets in Thailand. Viruses. 2020. DOI: https://doi.org/10.3390/v12040361

[48] Watson AM, Cushing A, Sheldon JD, Anis E, Wilkes R, Dubovi E, et al.. Natural Canine Distemper Virus Infection in Linnaeus’s 2-Toed Sloths (Choloepus didactylus). Veterinary Pathology-Supplement. 2020. DOI: https://doi.org/10.1177/0300985819900017

[49] Blasio AD, Irico L, Caruso C, Miceli I, Robetto S, Peletto S, et al.. CANINE DISTEMPER VIRUS AS AN EMERGING MULTIHOST PATHOGEN IN WILD CARNIVORES IN NORTHWEST ITALY.. Journal of Wildlife Diseases. 2019. DOI: https://doi.org/10.7589/2018-09-226

[50] Ahmad M, Hashmi H, Hassan M, Khaliq A, Shah S, Maqbool B, et al.. CHALLENGES IN DEVELOPING VACCINE FOR CANINE DISTEMPER. Biological and Clinical Sciences Research Journal. 2024. DOI: https://doi.org/10.54112/bcsrj.v2024i1.1159

[51] Moessner H, Brunt S, Díaz A, Davis AD. Coinfection of Canine Distemper Virus and Rabies Virus in Wildlife Samples Submitted for Routine Rabies Testing. Journal of Wildlife Diseases. 2023. DOI: https://doi.org/10.7589/JWD-D-21-00158

[52] Thomas N, White C, Saliki J, Schuler K, Lynch D, Nielsen O, et al.. CANINE DISTEMPER VIRUS IN THE SEA OTTER (ENHYDRA LUTRIS) POPULATION IN WASHINGTON STATE, USA. Journal of Wildlife Diseases. 2020. DOI: https://doi.org/10.7589/JWD-D-19-00008

[53] Suwanpakdee S, Wiratsudakul A, Chaisilp N, Prasittichai L, Skulpong A, Maneeorn P, et al.. Canine distemper outbreak and laryngeal paralysis in captive tigers (Panthera tigris). BMC Veterinary Research. 2025. DOI: https://doi.org/10.1186/s12917-025-04490-9

[54] Brown AT, McAloose D, Calle P, Auer A, Posautz A, Slavinski S, et al.. Development and validation of a portable, point-of-care canine distemper virus qPCR test. PLoS ONE. 2020. DOI: https://doi.org/10.1371/journal.pone.0232044

[55] Stilwell J, Anis E, Wilkes R, Rissi D. Dual infection with an emergent strain of canine distemper virus and canine parvovirus in an Arctic wolf under managed care. Journal of Veterinary Diagnostic Investigation. 2019. DOI: https://doi.org/10.1177/1040638719851832

[56] Francesco CDD, Smoglica C, Angelucci S. Infectious Diseases and Wildlife Conservation Medicine: The Case of the Canine Distemper in European Wolf Population. Animals. 2020. DOI: https://doi.org/10.3390/ani10122426

[57] Costa VGd, Saivish M, Rodrigues R, Silva RFdL, Moreli M, Krüger R. Molecular and serological surveys of canine distemper virus: A meta-analysis of cross-sectional studies. PLoS ONE. 2019. DOI: https://doi.org/10.1371/journal.pone.0217594

[58] Vlad GF, Dégi J, Iorgoni V, Degi D, Purec D, Iancu I, et al.. Prevalence of canine distemper virus in wild canids of Timiș County. Romanian Journal of Veterinary Sciences. 2025. DOI: https://doi.org/10.59463/rjvs.2025.3.26

[59] Muñoz-Hernández C, Wipf A, Ortega N, Barbera G, Salinas J, Gonzálvez M, et al.. Serological and molecular survey of canine distemper virus in red foxes (Vulpes vulpes): Exploring cut-off values and the use of protein A in ELISA tests.. Preventive Veterinary Medicine. 2023. DOI: https://doi.org/10.1016/j.prevetmed.2023.106075

[60] McDermott I, Gilbert M, Shah M, Sadaula A, Anderson N. Seroprevalence of canine distemper virus (CDV) in the free-roaming dog (Canis familiaris) population surrounding Chitwan National Park, Nepal. PLoS ONE. 2023. DOI: https://doi.org/10.1371/journal.pone.0281542

[61] Suzuki J, Nishio Y, Kameo Y, Terada Y, Kuwata R, Shimoda H, et al.. Canine distemper virus infection among wildlife before and after the epidemic. Journal of Veterinary Medical Science. 2015. DOI: https://doi.org/10.1292/jvms.15-0237

[62] Fornazari F, Sevá AP, Oliveira K, Assunção PCF, Guimarães V. Exposure of dogs and wild carnivores to canine distemper virus, canine parvovirus, Leishmania infantum, and Toxoplasma gondii in the Xingu River basin, Brazilian Amazon: Prevalence, spatial distribution, and association with land cover types. Acta Amazonica. 2023. DOI: https://doi.org/10.1590/1809-4392202301340

[63] Sersea M, Gurău M, Otelea F, Șonea C. Reviewed Comparative Analysis of Three Case-Studies Using RT-PCR to Detect Canine Distemper Virus. Annals "Valahia" University of Targoviste - Agriculture. 2022. DOI: https://doi.org/10.2478/agr-2022-0001

[64] Ogbu K, Ezema K, Chukwudi IC, Abdullahi M, Maikasua HA, Magaji AD, et al.. First report of canine distemper viral antigen and its associated risk factors in wild animals in Jos, Northern Nigeria: A Survey. Journal of Animal Science and Veterinary Medicine. 2025. DOI: https://doi.org/10.31248/jasvm2024.481

[65] Selleck MR, Johnson SR, Gilbert AT. SEROLOGICAL RESPONSE TO CANINE DISTEMPER VACCINATION IN WILD CAUGHT RACCOONS (PROCYON LOTOR). Journal of zoo and wildlife medicine. 2024. DOI: https://doi.org/10.1638/2023-0078

[66] Huang J, Cortey M, Darwich L, Griffin J, Obón E, Molina R, et al.. Study of Canine Distemper Virus Presence in Catalonia’s Wild Carnivores through H Gene Amplification and Sequencing. Animals. 2024. DOI: https://doi.org/10.3390/ani14030436

[67] Lazarus BA, Sadali MFM, Kamal FM, Hua KK, Wahab RA, Kaderi MA, et al.. Preliminary Study on the Development of a Transmission Model for Canine Distemper Virus in Wildlife Populations Using Heat Mapping and the Basic Reproduction Number. Veterinary Sciences. 2026. DOI: https://doi.org/10.3390/vetsci13010083

[68] Almuna R, López-Pérez A, Sarmiento RE, Suzán G. Drivers of canine distemper virus exposure in dogs at a wildlife interface in Janos, Mexico. Veterinary Record Open. 2021. DOI: https://doi.org/10.1002/vro2.7

[69] Wheelhouse J, Mak S, Legrand R, Eames JC, Proboste T, Meek P, et al.. Seroprevalence of canine distemper virus antibodies in free-roaming dogs in Cambodia.. The Veterinary Journal. 2024. DOI: https://doi.org/10.1016/j.tvjl.2024.106293

[70] Vlad GF, Dégi J, Iorgoni V, Degi D, Purec D, Iancu I, et al.. Seroprevalence of canine distemper virus in urban dogs from Timisoara. Romanian Journal of Veterinary Sciences. 2025. DOI: https://doi.org/10.59463/rjvs.2025.3.23

[71] Dorji T, Tenzin T, Tenzin K, Tshering D, Rinzin K, Phimpraphai W, et al.. Seroprevalence and risk factors of canine distemper virus in the pet and stray dogs in Haa, western Bhutan. BMC Veterinary Research. 2020. DOI: https://doi.org/10.1186/s12917-020-02355-x

[72] Du X, Goffin E, Gillard L, Machiels B, Gillet L. A Single Oral Immunization with Replication-Competent Adenovirus-Vectored Vaccine Induces a Neutralizing Antibody Response in Mice against Canine Distemper Virus. Viruses. 2022. DOI: https://doi.org/10.3390/v14091847

[73] Huo H, Wang H, Liang S, Wang Z, Wang J, Wang Q, et al.. Safety and Immunogenicity of a Canine Distemper DNA Vaccine Formulated with Lipid Nanoparticles in Dogs, Foxes, and Raccoon Dogs. Vaccines. 2025. DOI: https://doi.org/10.3390/vaccines13060614

[74] Ng D, Carver S, Gotame M, Karmasharya D, Karmacharya D, Pradhan S, et al.. Canine distemper in Nepal's Annapurna Conservation Area – Implications of dog husbandry and human behaviour for wildlife disease. bioRxiv. 2019. DOI: https://doi.org/10.1371/journal.pone.0220874